query,response,reference,correctness_score,semantic_similarity_score,answer_relevancy_score
What regulatory milestones has CytoSorb achieved in the United States?,"CytoSorb has achieved several regulatory milestones in the United States, including:

1. **FDA Clearance for Extracorporeal Cytokine Removal (ECR) Device**: In 2019, the U.S. Food and Drug Administration (FDA) granted CytoSorb Inc. 510(k) clearance for its CytoSorb® device, allowing it to be marketed for the removal of cytokines and other inflammatory mediators from blood during extracorporeal circulation. This clearance was based on the device's predicate device, the CytoSorb® 150, and was intended for use in patients with sepsis, cytokine storm, or other conditions associated with hyperinflammation.

2. **Investigational Device Exemption (IDE) for Clinical Trials**: The company has obtained FDA approval for IDEs to conduct clinical trials evaluating the use of CytoSorb in various critical care settings, including sepsis and COVID-19-related cytokine storm.

3. **Emergency Use Authorization (EUA) for COVID-19**: During the pandemic, CytoSorb was granted FDA EUA for use in patients with severe or life-threatening COVID-19 who are experiencing cytokine storm, allowing its use in the management of hyperinflammatory conditions.

These milestones reflect CytoSorb's progress in gaining regulatory access for its device in the U.S. market, primarily in the context of managing inflammatory conditions.","CytoSorb has received FDA Breakthrough Designation for the removal of ticagrelor in a cardiopulmonary bypass circuit during emergent and urgent cardiothoracic surgery, and Emergency Use Authorization (EUA) for use in critically-ill patients with COVID-19 infection.",5.0,0.6451173535067972,1.0
What are the commercialization strategies for CytoSorb in different regions?,I don't know.,"CytoSorbents Corporation employs a mixed strategy of direct sales through its subsidiaries in key markets like Germany, Austria, and Switzerland, and distribution through strategic partners and independent distributors in other countries, leveraging CE Mark approval for European markets and actively seeking registrations worldwide.",1.0,0.24646564178638675,0.0
What are the financial implications of using CytoSorb in treating sepsis patients?,I don't know.,"The use of CytoSorb in sepsis treatment is expected to improve clinical outcomes and reduce the need for costly ICU care, potentially saving significant healthcare costs. The therapy typically costs between $1,000 to $5,000, representing a fraction of the average cost of treating a severe sepsis patient, which can range from $45,000 to $60,000.",1.0,0.17121175729701552,0.0
What are the key risks associated with the discovery and development of our product candidates?,I don't know.,"The key risks include potential adverse impacts from COVID-19 on clinical trials, dependency on the success of lead product candidates, uncertainty of regulatory approval, and the high risk of failure in clinical trials.",1.0,0.22575807251679353,0.0
How does the COVID-19 pandemic affect our ability to conduct clinical trials?,"The COVID-19 pandemic has significantly impacted clinical trials by causing delays in trial initiation, recruitment, and data collection due to lockdowns, healthcare resource reallocations, and safety concerns. Many trials were paused or modified to reduce in-person visits, with increased reliance on remote monitoring and telemedicine. Supply chain disruptions affected the availability of study drugs and devices, while regulatory agencies implemented flexible guidelines to maintain trial safety and continuity. Additionally, some trials were repurposed to evaluate potential treatments for COVID-19, altering research priorities.","The COVID-19 pandemic may delay startup of new clinical trial sites, reduce patient enrollment, and disrupt operations of third-party suppliers and manufacturers, leading to delays or disruptions in the supply of product candidates for clinical trials.",5.0,0.7166861102290767,1.0
"What are the potential consequences of failing to comply with environmental, health, and safety laws and regulations?","Failing to comply with environmental, health, and safety laws and regulations can result in significant consequences, including:

1. **Fines and Penalties**: Regulatory agencies may impose monetary fines for violations, which can accumulate over time or be substantial for repeated or severe infractions.

2. **Legal Actions**: Companies or individuals may face lawsuits from government agencies, affected communities, or individuals for damages caused by non-compliance.

3. **Criminal Charges**: In cases of willful or gross negligence, responsible individuals may be subject to criminal prosecution, which can lead to imprisonment.

4. **Operational Disruptions**: Authorities may issue shutdown orders, halt production, or revoke permits, leading to business interruptions and financial losses.

5. **Reputational Damage**: Non-compliance can harm a company’s public image, leading to loss of customer trust, investor confidence, and business opportunities.

6. **Increased Insurance Costs**: Non-compliant entities may face higher premiums or be denied coverage due to increased risk.

7. **Liability for Environmental Remediation**: Companies may be required to clean up contamination or restore affected environments at their own expense.

8. **Loss of Licenses or Permits**: Regulatory bodies may revoke or suspend business licenses, hindering operations.

9. **Employee Health and Safety Risks**: Non-compliance can lead to workplace injuries or illnesses, resulting in higher workers’ compensation claims and reduced productivity.

10. **Long-Term Financial Impact**: The cumulative costs of fines, legal fees, remediation, and lost revenue can significantly affect a company’s financial stability.","Non-compliance could result in fines, penalties, or increased costs associated with remediation, and could potentially harm our business operations and reputation.",5.0,0.6722039455736044,1.0
"How does the company's international operations expose it to additional risks, and what measures does it take to mitigate these risks?",I don't know.,"The company's international operations expose it to risks such as challenges caused by distance, language, and cultural differences, as well as varying legal, economic, and political conditions in different countries. To mitigate these risks, the company employs various strategies, including compliance with local laws and regulations, careful selection of markets, and diversification of operations across different jurisdictions.",1.0,0.1614445369970476,0.0
"What are the potential impacts of data privacy and security laws on the company's operations, and how does it ensure compliance with these regulations?","Data privacy and security laws can impact a company's operations by requiring changes to data handling practices, increasing compliance costs, necessitating staff training, and imposing penalties for non-compliance. These laws may also affect product development, international operations, and customer trust.

To ensure compliance, the company typically implements data protection policies, conducts regular audits, encrypts sensitive data, limits data collection to what is necessary, provides clear privacy notices, obtains user consent, appoints a data protection officer if required, and stays updated on regulatory changes.","Data privacy and security laws, such as the GDPR and CCPA, impose stringent requirements on the collection, storage, and use of personal information, which could increase the company's costs and expose it to potential sanctions and lawsuits if not complied with. The company ensures compliance through implementing robust data protection measures, regular audits, and staying updated on regulatory changes to adapt its practices accordingly.",5.0,0.7958519003324526,1.0
"What was the total amount of revenue expected to be recognized from remaining performance obligations as of March 31, 2020?",I don't know.,"As of March 31, 2020, approximately $24.0 billion of revenue was expected to be recognized from remaining performance obligations.",1.0,0.26199018796609097,0.5
What were the major elements contributing to the difference between the U.S. federal statutory tax rate and the effective tax rate in fiscal 2020?,"The major elements contributing to the difference between the U.S. federal statutory tax rate and the effective tax rate in fiscal 2020 include:  
1. **Tax deductions and credits** (such as the research and development tax credit and foreign tax credits),  
2. **Accelerated depreciation** and other tax incentives that reduce taxable income,  
3. **Tax treatments for intangible assets and intellectual property**,  
4. **Global intangible low-taxed income (GILTI) provisions** under the Tax Cuts and Jobs Act of 2017,  
5. **State and local tax (SALT) deductions**,  
6. **Repatriation of foreign earnings** and associated taxes,  
7. **Use of tax loss carryforwards** and other provisions to offset taxable income.  

These factors reduced the effective tax rate below the statutory rate of 21% in 2020.","The major elements contributing to the difference in fiscal 2020 included a non-deductible goodwill impairment charge, a non-taxable gain on an arbitration award, a change in the net valuation allowance on certain deferred tax assets, and an increase in Income Tax and Foreign Tax Credits.",3.0,0.6116626932195467,1.0
How did the Company's annual goodwill impairment analysis in fiscal 2020 differ from previous years?,I don't know.,"In fiscal 2020, the Company performed quantitative goodwill impairment tests during the second and fourth quarters due to a sustained decline in the Company’s stock price and market capitalization, leading to the recognition of total non-cash impairment charges of $6,794 million. This was a departure from previous years where no such impairments were recognized.",1.0,0.2389662257024684,0.0
How did the Company's approach to managing foreign currency risk through derivative instruments evolve in fiscal 2020?,I don't know.,"The Company continued to use foreign currency forward contracts as cash flow hedges to reduce foreign currency risk related to certain intercompany obligations and forecasted transactions. The notional amounts of these contracts designated as cash flow hedges increased to $455 million as of March 31, 2020, from $277 million as of March 31, 2019.",1.0,0.19611029499212843,0.0
"How does the company plan to commercialize its product candidates, and what are the associated risks?",I don't know.,"The company plans to directly market and commercialize its product candidates by developing its own sales and marketing force. The associated risks include the potential for increased expenses, the inability to hire and retain qualified personnel, and the possibility of failing to build a successful commercial infrastructure.",1.0,0.21224016564748024,0.0
What are the potential impacts of the COVID-19 pandemic on the company's business operations?,I don't know.,"The COVID-19 pandemic could disrupt the company's preclinical studies, clinical trials, and operations, potentially leading to delays in patient enrollment, difficulties in conducting trials, and interruptions in the supply chain for its product candidates.",1.0,0.2662072380188259,0.0
How does the company's reliance on third-party contract manufacturing organizations (CMOs) impact its operations?,I don't know.,"The company's reliance on CMOs exposes it to risks such as supply chain disruptions, potential manufacturing defects, and the inability to quickly transition to alternative suppliers if needed, which could delay product development and commercialization.",1.0,0.24900560455283277,0.0
What are the potential consequences of the company's failure to comply with healthcare laws and regulations?,"The potential consequences of a company's failure to comply with healthcare laws and regulations can include fines, penalties, legal actions, loss of licensing or accreditation, damage to reputation, exclusion from government healthcare programs (such as Medicare or Medicaid), and in severe cases, criminal charges against executives or employees. Additionally, non-compliance may result in increased scrutiny from regulatory bodies and costly corrective actions.","Failure to comply with healthcare laws and regulations could result in significant legal, financial, and reputational harm, including the imposition of civil, criminal, and administrative penalties, damages, monetary fines, and potential exclusion from participation in government healthcare programs.",5.0,0.8887171522499125,1.0
What are the risks associated with the company's reliance on collaborations and licensing arrangements?,I don't know.,"The company's reliance on collaborations and licensing arrangements exposes it to risks such as the potential for partners to shift priorities, terminate agreements, or fail to fulfill their obligations, which could delay or prevent the development and commercialization of its product candidates.",1.0,0.2706039346141089,0.0
What are the potential benefits of intrathecal administration of AAV9-based gene therapies?,"The potential benefits of intrathecal administration of AAV9-based gene therapies include targeted delivery to the central nervous system (CNS), improved transduction of neurons and glial cells, reduced systemic exposure, and enhanced efficacy for treating neurological disorders. This route allows for direct access to the cerebrospinal fluid, facilitating widespread distribution throughout the CNS, which is particularly beneficial for conditions such as spinal muscular atrophy, lysosomal storage diseases, and other neurometabolic disorders. Additionally, intrathecal delivery may reduce the required therapeutic dose and minimize immune responses compared to systemic administration.","The potential benefits of intrathecal administration of AAV9-based gene therapies include optimal biodistribution and cell transduction within the CNS, administration even in the presence of pre-existing antibodies to AAV, and limited exposure to peripheral organs.",4.5,0.8637625297673821,1.0
How does the company plan to finance its cash needs in the future?,I don't know.,"The company plans to finance its cash needs through a combination of equity offerings, government or private party grants, debt financings, and license and collaboration agreements.",1.0,0.18784888507425207,1.0
What are the risks associated with the company's reliance on third-party suppliers for materials used in the manufacture of its product candidates?,I don't know.,"Risks include limited control over pricing, availability, and quality of materials, potential supply interruptions, and increased costs if alternative suppliers need to be found, which could delay clinical trials and commercialization efforts.",1.0,0.24528138086089107,0.0
How does the company's dependence on collaboration with UT Southwestern affect its research and development programs?,I don't know.,The company's dependence on UT Southwestern for preclinical research and development programs could lead to delays or failures in its development efforts if UT Southwestern fails to fulfill its obligations or if there is a breakdown in collaboration.,1.0,0.24413778934679445,0.0
"How did the adoption of ASC Topic 842 affect the Company's Consolidated Balance Sheets as of August 3, 2019?",I don't know.,The adoption of ASC Topic 842 resulted in the recognition of operating lease liabilities with corresponding right-of-use assets of approximately the same amount based on the present value of the remaining lease payments for existing operating leases.,1.0,0.2247871901412795,0.0
How did the Company account for the Supervalu acquisition in terms of goodwill and intangible assets?,I don't know.,"In conjunction with the Supervalu acquisition, goodwill resulting from the acquisition was assigned to the previous Supervalu Wholesale reporting unit and the legacy Company Wholesale reporting unit. Identifiable intangible assets were also recorded based on final valuations, with expected useful lives ranging from 5 to 20 years.",1.0,0.2382183414287763,0.0
How did the Company's defined benefit pension plans perform in fiscal 2020 in terms of contributions and obligations?,I don't know.,No minimum pension contributions were required to be made under either the SUPERVALU INC. Retirement Plan or the Unified Grocers pension plan in fiscal 2020. The Company expected to contribute approximately $0.0 million to $5.3 million to its other defined benefit pension plans and postretirement benefit plans in fiscal 2021.,1.0,0.26122314152662846,0.0
How did the adoption of the CARES Act affect the Company's deferred tax assets and liabilities?,I don't know.,"The CARES Act allowed the Company to carry back net operating losses, resulting in a tax benefit of approximately $39.5 million. This was recorded as a current tax receivable in the Consolidated Balance Sheet as of August 1, 2020.",1.0,0.15227168716663256,0.0
How did the Company's decision to reclassify Retail operations from discontinued to continuing operations affect the financial statements?,I don't know.,"The reclassification resulted in the inclusion of Retail’s results of operations, financial position, and cash flows within continuing operations for all periods, affecting the presentation but not the underlying financial performance or position.",1.0,0.23893965123506275,0.0
"What was the total net revenue for Quest Diagnostics in 2020, and how did it compare to the previous year?","The total net revenue for Quest Diagnostics in 2020 was $12.46 billion, representing a 3.4% increase compared to the previous year.","The total net revenue for Quest Diagnostics in 2020 was $9.4 billion, which was up 22.1% from the previous year.",2.0,0.9662605115005919,1.0
How did the COVID-19 pandemic impact Quest Diagnostics' testing volume and revenues in 2020?,"In 2020, the COVID-19 pandemic significantly impacted Quest Diagnostics' testing volume and revenues. The company saw a substantial increase in demand for COVID-19 testing services, which led to a dramatic rise in testing volume. As a result, Quest Diagnostics reported a significant boost in revenue, primarily driven by the surge in testing demand during the pandemic. The company's revenues from diagnostic testing, particularly COVID-19 testing, contributed substantially to its overall financial performance in 2020.","The COVID-19 pandemic led to a decline in testing volume in Quest Diagnostics' base business by 11.4% in 2020, but this was more than offset by increased demand for COVID-19 molecular and antibody testing, which drove a 23.4% increase in revenues in the DIS business.",3.0,0.8250738989886436,1.0
How did Quest Diagnostics' capital expenditures and investments in technology and infrastructure evolve in 2020?,I don't know.,"Quest Diagnostics invested approximately $350 million to $400 million in capital expenditures in 2020, focusing on investments in information technology, laboratory equipment and facilities, including COVID testing equipment, and completion of a new multi-year laboratory construction in New Jersey.",1.0,0.2853344127005266,0.0
"What were the key financial covenants associated with Quest Diagnostics' credit facilities, and how were they amended in 2020?",I don't know.,"The key financial covenant associated with Quest Diagnostics' credit facilities was the maintenance of a financial leverage ratio. In 2020, the Company amended the Credit Facility to provide increased covenant flexibility, increasing the leverage ratio covenant temporarily to provide more flexibility during the COVID-19 pandemic.",1.0,0.2302009489516845,0.0
What are the primary risks related to the company's financial condition and capital requirements?,I don't know.,"The company faces risks including a limited operating history, significant ongoing losses, and the need for additional funding to expand commercialization and development efforts. Failure to obtain necessary capital could force the company to delay or terminate product commercialization or development efforts.",1.0,0.3091371462759483,0.0
How does the company's reliance on a single supplier for key components impact its operations?,"The company's reliance on a single supplier for key components can increase operational risk, as it makes the company vulnerable to supply chain disruptions, price fluctuations, and quality issues. If the supplier experiences production problems, logistical delays, or financial difficulties, the company may face production delays, increased costs, or lost sales. Additionally, this dependency can reduce negotiating power and limit flexibility in sourcing alternatives, potentially impacting innovation and responsiveness to market changes.","The company's reliance on a single supplier, TSMC, for manufacturing and supplying wafers used in its probes poses a risk if TSMC fails to fulfill obligations or performs unsatisfactorily. This could negatively affect the company's ability to source its devices and potentially impact cash flows due to minimum purchase obligations.",4.0,0.6887131691262566,1.0
What are the cybersecurity risks associated with the company's operations?,I don't know.,"The company faces risks of cybersecurity incidents that could result in unauthorized access, data breaches, or operational disruptions, potentially leading to harm to customers, business interruptions, legal liabilities, reputational damage, and increased costs for remediation and protection.",1.0,0.3093180665806022,0.0
What are the risks associated with the company's reliance on open source software?,I don't know.,"Using open source software may expose the company to risks such as requirements to disclose source code, potential infringement claims, and the possibility that competitors could use the same open source software to create similar products. Failure to comply with open source licenses could restrict the company's ability to sell its products and lead to legal challenges.",1.0,0.22412026500670268,0.0
How does Brandywine Realty Trust account for acquisitions of real estate that do not meet the definition of a business?,"Brandywine Realty Trust accounts for acquisitions of real estate that do not meet the definition of a business as asset acquisitions. Under such circumstances, the purchase price is allocated to the individual assets acquired and liabilities assumed based on their fair values at the acquisition date. The excess of the purchase price over the fair value of the net assets acquired is recognized as goodwill, if applicable. This approach aligns with the accounting standards for business combinations and asset acquisitions.",Acquisitions of real estate that do not meet the definition of a business are accounted for as asset acquisitions. The acquisition consideration (including acquisition costs) is allocated to the individual assets acquired and liabilities assumed on a relative fair value basis.,4.0,0.795990987082436,1.0
What method does Brandywine Realty Trust use to depreciate its buildings and improvements?,Brandywine Realty Trust uses the straight-line method to depreciate its buildings and improvements over their estimated useful lives.,Brandywine Realty Trust uses the straight-line method to depreciate its buildings and improvements over lives ranging from the life of the lease to 55 years.,4.0,0.9652721090328519,1.0
How does Brandywine Realty Trust determine the fair value of its real estate investments for impairment assessments?,"Brandywine Realty Trust determines the fair value of its real estate investments for impairment assessments by using a combination of valuation methods, including but not limited to, discounted cash flow models, market comparables, and recent property sales data. These methods are applied in accordance with the Financial Accounting Standards Board (FASB) guidelines, particularly ASC 360-10, which governs the accounting for the impairment or disposal of long-lived assets. The fair value is assessed based on current market conditions, property-specific characteristics, and projected future cash flows, ensuring that any impairment charges reflect the current economic reality of the assets.","Brandywine Realty Trust determines the fair value of its real estate investments for impairment assessments using estimated undiscounted future cash flows expected to be generated from the operations and eventual disposition of the assets over, in most cases, a 10-year hold period. The estimates consider assumptions including market rental rates, capitalization rates, and recent sales data for comparable real estate investments.",4.0,0.8128617610187961,1.0
What are the key factors considered by Brandywine Realty Trust in its assessment of whether to consolidate a variable interest entity (VIE)?,"Brandywine Realty Trust considers the following key factors in assessing whether to consolidate a variable interest entity (VIE):

1. **Power to Direct Activities**: Whether the entity has the power to direct the activities that most significantly impact the VIE’s economic performance.
2. **Beneficial Interest**: Whether the entity has a significant financial interest in the VIE, including the potential for gains or losses from the VIE's activities.
3. **Substantive Risks and Rewards**: The extent to which the entity absorbs a majority of the VIE’s expected losses or receives a majority of its expected returns.
4. **Accounting Guidance**: Adherence to the relevant accounting standards, such as ASC 810 (Consolidation) and ASC 470 (Debt), which provide criteria for determining control and consolidation of VIEs.

These factors are evaluated to determine if Brandywine Realty Trust is the primary beneficiary of the VIE and must therefore consolidate it in its financial statements.","Brandywine Realty Trust considers whether it is the primary beneficiary of a VIE, which involves having both the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE.",4.5,0.7446008422968998,1.0
How has the COVID-19 pandemic impacted the company's underwriting results in 2020?,I don't know.,"The COVID-19 pandemic significantly impacted the company's underwriting results in 2020 by causing an underwriting loss due to pandemic-related catastrophe losses, which included event cancellation coverage for conferences and sporting events, business interruption claims, and related estimated legal expenses.",1.0,0.2596187008550769,0.0
What measures has the company taken to mitigate the impact of catastrophe events?,I don't know.,"The company has taken several measures to mitigate the impact of catastrophe events, including considering catastrophe risks in underwriting and pricing decisions, purchasing reinsurance, monitoring and modeling accumulated exposures, and managing exposure in key geographic zones and product lines prone to catastrophe events.",1.0,0.22534914607676823,0.5
"How does the company account for prior accident year loss reserve development, and what impact does it have on financial results?","The company accounts for prior accident year loss reserve development by adjusting its estimated liabilities for unpaid claims based on new information about the severity and frequency of past claims. These adjustments are recorded in the financial statements as changes in loss reserves. 

When reserves are increased (e.g., due to higher-than-expected claims), it results in higher expenses and lower net income. Conversely, when reserves are released (i.e., claims develop more favorably than expected), it leads to lower expenses and higher net income. This impact directly affects the company’s financial results, particularly its earnings and loss ratio. The reserve development is typically reflected in the ""change in loss reserves"" line item within the income statement.","The company accounts for prior accident year loss reserve development by periodically analyzing and adjusting the expected ultimate cost of liabilities to reflect favorable or unfavorable development in loss experience and new information. Adjustments to these reserves, both favorable and unfavorable, are reflected in the financial results of the periods in which these adjustments are made.",4.5,0.7309033500453966,1.0
"What is the role of non-GAAP financial measures in the company's financial analysis, and how are they reconciled with GAAP measures?","Non-GAAP financial measures are used by companies to provide additional insight into their operational performance by excluding certain items that may distort the understanding of core business results, such as one-time charges, stock-based compensation, or restructuring costs. These measures are often used to highlight trends in the company’s underlying performance and to assist investors in comparing results across periods or with competitors.

However, because non-GAAP measures are not standardized and are not prepared in accordance with Generally Accepted Accounting Principles (GAAP), companies are required to reconcile these measures to the most directly comparable GAAP financial measures. This reconciliation typically includes a detailed explanation of the adjustments made and their impact on the GAAP figures, ensuring transparency and allowing investors to understand the differences between the reported non-GAAP results and the GAAP results.","Non-GAAP financial measures, such as underwriting profit and adjusted earnings before income taxes, provide additional information to investors and analysts by highlighting specific aspects of performance that management believes are meaningful. These measures are not a substitute for GAAP measures and are reconciled with the most comparable GAAP financial measures in the financial statements.",4.5,0.7228626668536109,1.0
How has the company's capital structure and liquidity position been managed to support its operations during the financial year 2020?,I don't know.,"The company has managed its capital structure and liquidity position by maintaining a relatively liquid financial position at its unrestricted holding companies, issuing new senior notes, and utilizing credit facilities. These measures have ensured adequate funds for operational needs, including acquisitions and share repurchases, despite challenges posed by the COVID-19 pandemic.",1.0,0.17473322574967212,0.0
What are the key assumptions used in the valuation of Huntington Bancshares Incorporated's mortgage servicing rights (MSRs)?,"The key assumptions used in the valuation of Huntington Bancshares Incorporated's mortgage servicing rights (MSRs) include prepayment speeds (such as CPR or PSA), discount rates, default rates, servicing costs, and interest rates. These assumptions impact the expected cash flows from the servicing rights and the present value of those cash flows.","The key assumptions used in the valuation of Huntington Bancshares Incorporated's MSRs include the discount rate, prepayment speed, and the servicing fee. These assumptions are used in a discounted future cash flow model to estimate the fair value of MSRs.",4.5,0.9420900239604533,1.0
What is the significance of the allowance for credit losses (ACL) in the context of Huntington Bancshares Incorporated's financial reporting?,"The allowance for credit losses (ACL) is significant in Huntington Bancshares Incorporated's financial reporting as it represents the amount of expected credit losses on its loan portfolio. It is a key component of the bank's financial health, reflecting the potential losses from borrowers who may default on their loans. The ACL is established under the Current Expected Credit Loss (CECL) model, which requires financial institutions to estimate expected credit losses over the life of the loans, thereby ensuring that losses are recognized earlier and more proactively. This enhances the transparency and accuracy of the bank's financial statements, allowing investors and regulators to better assess the bank's risk exposure and overall financial stability.","The allowance for credit losses (ACL) is significant in Huntington Bancshares Incorporated's financial reporting as it represents the amount set aside to cover potential credit losses on financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. The ACL is deducted from the amortized cost basis of a financial asset or a group of financial assets so that the balance sheet reflects the net amount Huntington expects to collect.",5.0,0.9129238539787583,1.0
How does Huntington Bancshares Incorporated manage its interest rate risk through derivative financial instruments?,"Huntington Bancshares Incorporated manages its interest rate risk through the use of derivative financial instruments such as interest rate swaps, swaptions, and futures contracts. These instruments allow the company to hedge against fluctuations in interest rates by modifying the interest rate characteristics of its assets, liabilities, or off-balance-sheet items. For example, the company may enter into interest rate swaps to convert fixed-rate assets or liabilities into floating-rate instruments, or vice versa, to align interest rate exposures with its risk management objectives. Additionally, Huntington may use futures contracts to hedge specific rate-sensitive positions. The company discloses its use of derivatives and risk management strategies in its annual reports and regulatory filings, consistent with accounting standards such as ASC 815.","Huntington Bancshares Incorporated manages its interest rate risk through the use of derivative financial instruments, principally interest rate swaps, caps, floors, and collars. These instruments provide flexibility in adjusting Huntington’s sensitivity to changes in interest rates without exposure to loss of principal and higher funding requirements. They are used in asset and liability management activities to protect against the risk of adverse price or interest rate movements.",4.5,0.894473431107647,1.0
What was the total acquisition-date fair value of consideration transferred in the Sprint Merger?,I don't know.,The total acquisition-date fair value of consideration transferred in the Sprint Merger was $40.8 billion.,1.0,0.2759422689879215,1.0
How much did T-Mobile pay in Commitment Letter fees to certain financial institutions in connection with the Merger?,I don't know.,T-Mobile paid $355 million in Commitment Letter fees to certain financial institutions in connection with the Merger.,1.0,0.2604375853393779,1.0
"What was the impact of the new credit loss standard on the allowance for credit losses as of January 1, 2020?","The new credit loss standard, CECL (Current Expected Credit Loss), required financial institutions to recognize losses based on expected credit losses over the life of the financial asset, rather than waiting for a loss to be probable. As of January 1, 2020, this led to an increase in the allowance for credit losses for many institutions, as they had to estimate expected losses over the entire life of the loans, resulting in higher reserves than under the previous incurred loss model.","The new credit loss standard resulted in an increase to the allowance for credit losses of $91 million as of January 1, 2020.",4.0,0.7465772602273022,1.0
"What was the total principal amount of Senior Secured Notes issued by T-Mobile USA on April 9, 2020?",I don't know.,"The total principal amount of Senior Secured Notes issued by T-Mobile USA on April 9, 2020 was $19.0 billion.",1.0,0.25625784066831253,1.0
What are the primary risks associated with investing in the shares of the company as outlined in the financial report?,I don't know.,"The primary risks include the company's lack of an operating history, potential for significant fluctuations in quarterly results, and the risk of not achieving investment objectives due to market conditions and competition.",1.0,0.3154414356368002,0.0
How does the company's status as a non-diversified investment company under the 1940 Act affect its investment strategy?,"Being classified as a non-diversified investment company under the 1940 Act allows the company to invest a larger portion of its assets in a smaller number of issuers. This means the company is not required to maintain the same level of diversification as a diversified fund, enabling it to concentrate its investments in specific sectors, industries, or securities. This concentration can lead to higher potential returns but also increases the risk of loss if the investments perform poorly. The company may also have greater flexibility in managing its portfolio, but this comes with the trade-off of potentially greater volatility.","As a non-diversified investment company, the company is not limited in the proportion of assets it may invest in securities of a single issuer, which may increase the volatility of its NAV and make it more susceptible to economic or regulatory occurrences.",5.0,0.7210560244783492,1.0
What measures does the company take to mitigate the risk of unrealized losses on its portfolio?,I don't know.,"The company values its investments at market value or fair value as determined in good faith by its Board of Trustees, considering various factors such as the estimated enterprise value of a portfolio company, the nature and realizable value of collateral, and the portfolio company’s ability to make payments based on its earnings and cash flow.",1.0,0.24338737343597192,0.0
How does the company plan to address the risk of fluctuations in interest rates affecting its cost of capital and net investment income?,I don't know.,"The company may use interest rate risk management techniques, including various interest rate hedging activities to the extent permitted by the 1940 Act, to limit its exposure to interest rate fluctuations.",1.0,0.22731144555175709,0.0
What are the potential consequences if the company fails to maintain its status as a Business Development Company (BDC)?,"If a company fails to maintain its status as a Business Development Company (BDC), it may lose the tax advantages associated with BDC status, including the ability to avoid corporate-level income tax on distributions to shareholders, provided it meets certain requirements. Additionally, the company could face penalties, be subject to higher tax rates, and may need to restructure its operations to comply with alternative regulatory frameworks. Loss of BDC status may also impact investor confidence and the company's ability to raise capital, as BDC status is often valued by investors seeking tax-efficient investments.","If the company fails to maintain its BDC status, it could be regulated as a registered closed-end investment company under the 1940 Act, subjecting it to more regulatory restrictions and potentially decreasing its operating flexibility.",4.0,0.6975753464989717,1.0
How does the company manage the risk of default by portfolio companies on their debt obligations?,I don't know.,The company may incur expenses to seek recovery upon default or to negotiate new terms with defaulting portfolio companies. It also relies on the investment expertise and network of business contacts of the Adviser and its affiliates to monitor and service its investments.,1.0,0.24490229980718087,0.0
What are the implications of Intec Israel being characterized as a passive foreign investment company (PFIC) for U.S. shareholders?,"If Intec Israel is characterized as a passive foreign investment company (PFIC), U.S. shareholders may face significant tax consequences. These include:

1. **Adverse Tax Treatment**: Distributions from a PFIC are treated as ordinary income, and any gain on the sale of PFIC stock is treated as ordinary income, rather than capital gains.

2. **Excess Distribution and Deferred Tax on Gain**: If a U.S. shareholder receives a distribution from a PFIC, it may be subject to special rules that treat it as an ""excess distribution,"" which is taxed as if it were a deemed dividend, potentially resulting in a higher tax rate.

3. **Interest Charges**: A U.S. shareholder may be required to pay additional interest charges on taxes owed due to the delayed recognition of income or gains.

4. **Complex Reporting Requirements**: U.S. shareholders must file Form 8621 to report their PFIC investments, which requires detailed reporting and can result in complex tax computations.

5. **Election Option (QEF or Mark-to-Market)**: Shareholders may elect to treat the PFIC as a Qualified Electing Fund (QEF) or, in certain cases, use the mark-to-market method, which could mitigate some of the adverse tax effects, but these elections come with strict compliance requirements.

Overall, the PFIC classification can result in higher taxes and greater administrative burdens for U.S. shareholders.","U.S. shareholders of a PFIC may face adverse tax consequences, including having gains classified as ordinary income, loss of preferential tax rates on dividends, and application of interest charges to distributions and share sales.",5.0,0.7488284898367713,1.0
How did the adoption of the Current Expected Credit Loss (CECL) model affect the Company's financial statements in 2020?,I don't know.,"Upon adoption of CECL on January 1, 2020, the Company recorded a cumulative effect adjustment to decrease retained earnings by $25,018, with corresponding adjustments to the allowance for credit losses on loans and unfunded commitments.",1.0,0.21917292364310165,0.0
What significant mergers and acquisitions did FB Financial Corporation complete in 2020?,I don't know.,"FB Financial Corporation completed mergers with Franklin Financial Network, Inc. on August 15, 2020, and FNB Financial Corp. on February 14, 2020.",1.0,0.1876008620666857,0.0
How did the Company's allowance for credit losses change in 2020 due to the acquisitions of Franklin and FNB Financial Corp.?,I don't know.,"The acquisitions of Franklin and FNB Financial Corp. increased the allowance for credit losses by $77,653 and $4,494, respectively, as of their acquisition dates.",1.0,0.22075729334074537,0.0
"What was the impact of the PPP loans on the Company's loan portfolio as of December 31, 2020?",I don't know.,"As of December 31, 2020, the Company had $212,645 of loans originated as part of the PPP, which are federally guaranteed and have minimal credit risk associated with them.",1.0,0.2621032637310417,0.5
How did the Company's investment in Federal Home Loan Bank (FHLB) stock affect its financial position?,I don't know.,"The Bank accounts for its investments in FHLB stock at cost and evaluates them for impairment. As of December 31, 2020, the investment in FHLB stock was carried at cost and evaluated for impairment.",1.0,0.2418696820525996,0.0
What were the quarterly earnings per share (EPS) for FB Financial Corporation in 2020?,I don't know.,"The quarterly EPS for FB Financial Corporation in 2020 were as follows: Q1 - $0.71, Q2 - $0.95, Q3 - $1.00, and Q4 - $1.11.",1.0,0.20439064707459514,0.5
How does the ongoing COVID-19 pandemic potentially affect the company's operations?,I don't know.,"The COVID-19 pandemic could materially affect the company's operations, including clinical development, sales and marketing efforts, supply chain operations, research and development activities, and fundraising activities, potentially leading to delays or disruptions.",1.0,0.28464272849907896,0.0
How does the company's reliance on third-party manufacturers for the production of its product candidates pose risks?,"The company's reliance on third-party manufacturers for the production of its product candidates poses several risks, including:  

1. **Supply Chain Disruptions**: Third-party manufacturers may face operational issues, such as natural disasters, labor strikes, or equipment failures, leading to delays or interruptions in production.  
2. **Quality Control Issues**: The company may have limited direct oversight over manufacturing processes, increasing the risk of quality deviations or non-compliance with regulatory standards.  
3. **Capacity Constraints**: If the manufacturer is operating at full capacity or experiences increased demand, the company may face shortages or delayed deliveries.  
4. **Regulatory Risks**: Any failure by the manufacturer to comply with Good Manufacturing Practices (GMP) or other regulatory requirements can result in product recalls, delays in regulatory approval, or penalties.  
5. **Intellectual Property Risks**: Sharing proprietary processes or formulas with third parties may expose the company to the risk of IP theft or unauthorized use.  
6. **Cost Volatility**: Changes in raw material prices or labor costs at the manufacturer could lead to increased production costs, impacting profitability.  
7. **Contractual Disputes**: Disagreements over pricing, delivery timelines, or quality standards could lead to legal conflicts or disruptions in supply.  
8. **Limited Flexibility**: Relying on a third party may limit the company’s ability to quickly adapt to changing market demands or scale production as needed.  

These risks can affect the company’s ability to deliver products on time, maintain product quality, and comply with regulatory requirements, potentially impacting its market position and financial performance.","Reliance on third-party manufacturers carries risks such as potential breaches of manufacturing agreements, termination of agreements, reliance on the third party for regulatory compliance, quality assurance, and potential supply disruptions.",5.0,0.8007772885492236,1.0
What are the potential impacts of the company's limited operating history as a pharmaceutical company?,I don't know.,"The company's limited operating history makes it difficult to evaluate its future success and viability, and it may encounter risks and difficulties frequently experienced by early-stage pharmaceutical companies, which could adversely affect its business, operating results, and financial condition.",1.0,0.3396903857180276,0.0
How does the company's status as an emerging growth company and a smaller reporting company affect its disclosure requirements?,"The company's status as an emerging growth company and a smaller reporting company affects its disclosure requirements by allowing it to use scaled disclosure requirements. This means the company is exempt from certain requirements, such as the auditor attestation of internal control over financial reporting and the requirements for executive compensation disclosure. Additionally, it has reduced requirements for the disclosure of information regarding its executive compensation and is not required to have a compensation committee.","As an emerging growth company and a smaller reporting company, the company is permitted to rely on exemptions from certain disclosure requirements, which may make its common stock less attractive to investors and could affect the trading price of its stock.",4.5,0.7820531145207551,1.0
How did the COVID-19 pandemic impact VF's financial position as of March 2020?,I don't know.,The COVID-19 pandemic led VF to draw down $1.0 billion from its Global Credit Facility to strengthen its cash position and support general working capital needs.,1.0,0.24391156050213747,0.0
"What was the total amount of cash flow hedges used by VF as of March 2020, and how much was expected to be reclassified to earnings within the next 12 months?",I don't know.,"VF had $60.2 million of pre-tax net deferred gains for foreign currency exchange contracts in accumulated OCI as of March 2020, of which $60.2 million was expected to be reclassified to earnings within the next 12 months.",1.0,0.1750657191578451,0.0
How does the COVID-19 pandemic impact the company's commercial launch of TAZVERIK?,I don't know.,"The COVID-19 pandemic has limited the company's ability to access accounts and healthcare professionals, negatively impacted patient visits to physicians, and continued to disrupt commercialization efforts, which could result in adverse effects on the business and operations.",1.0,0.30243542512904925,0.0
What are the financial implications of the company's reliance on third-party manufacturers for the production of tazemetostat?,I don't know.,"Reliance on third-party manufacturers increases the risk of not having sufficient quantities of tazemetostat or such quantities at an acceptable cost or quality, which could delay, prevent, or impair development or commercialization efforts.",1.0,0.24348535416809022,0.0
How does the company's intellectual property portfolio affect its competitive position?,"A company's intellectual property (IP) portfolio strengthens its competitive position by protecting innovations, enabling market exclusivity, and creating barriers to entry for competitors. Patents, trademarks, copyrights, and trade secrets can provide legal rights to unique products, technologies, or brands, allowing the company to differentiate itself, capture market share, and generate revenue through licensing or enforcement. A robust IP portfolio also enhances a company's reputation and attractiveness to investors, further reinforcing its competitive advantage.","The company's ability to protect its intellectual property rights is crucial for maintaining a competitive edge. Failure to obtain, maintain, and enforce patent protection could allow competitors to develop and commercialize similar products, adversely affecting the company's business.",5.0,0.5488907820466488,1.0
What are the risks associated with the company's reliance on collaborations for product development and commercialization?,I don't know.,"Risks include collaborators' discretion in determining resource allocation, potential de-emphasis or termination of development programs, and the possibility of disagreements over proprietary rights or contract interpretation, which could adversely affect the company's business.",1.0,0.2299849457403949,0.0
What are the four reportable operating segments of Willis Towers Watson?,I don't know.,"The four reportable operating segments are Human Capital and Benefits (HCB), Corporate Risk and Broking (CRB), Investment, Risk and Reinsurance (IRR), and Benefits Delivery and Administration (BDA).",1.0,0.16242796445858962,0.0
What are the key assumptions used in the valuation of Willis Towers Watson's defined benefit pension plans?,I don't know.,"The key assumptions include discount rates, expected long-term rates of return on plan assets, rates of participant mortality, expected long-term rates of compensation and pension increases.",1.0,0.2255532765305618,0.0
How does Willis Towers Watson recognize revenue from broking services?,"Willis Towers Watson recognizes revenue from broking services over time as the services are performed, typically using the proportional performance method. Revenue is recognized in proportion to the satisfaction of performance obligations, which often aligns with the passage of time or completion of specific milestones under the terms of the client agreements. This approach reflects the continuous nature of broking services, where the company provides ongoing advice, risk management solutions, and insurance placement services to clients.","Revenue from broking services is recognized at the later of the policy inception date or when the policy placement is complete, as this is viewed as the date when control is transferred to the client.",3.0,0.652389938076632,1.0
What are the key risks and uncertainties related to the COVID-19 pandemic that Willis Towers Watson has considered in its financial statements?,I don't know.,"The key risks and uncertainties include the collectability of billed and unbilled receivables, the estimation of revenue, and the fair value of reporting units, tangible and intangible assets, and contingent consideration.",1.0,0.22858130677538865,0.0
"What is the total amount of remaining performance obligations as of December 31, 2020, and how is it expected to be recognized in future periods?",I don't know.,"As of December 31, 2020, approximately $8.4 billion of total revenues, including deferred installation revenues, are expected to be recognized in future periods, the majority of which will be recognized over the next 24 months.",1.0,0.23232943319475463,0.0
"How did the adoption of Topic 842 (Leases) impact the Company's financial results on January 1, 2019?",I don't know.,"On January 1, 2019, the adoption of Topic 842 resulted in the recognition of new ROU assets and liabilities on the balance sheet for all operating leases, and the de-recognition of existing build-to-suit assets and liabilities with a cumulative effect adjustment to retained earnings.",1.0,0.2284258803423488,0.0
"What are the key risks and uncertainties that may have a material adverse effect on the company's business, financial condition, or results of operations?",I don't know.,"The key risks include uncertainty regarding future revenue and access to funding, potential failure to develop or commercialize drug or biologic product candidates, clinical trial delays, reliance on third parties for management of clinical programs and manufacturing, extensive regulation by government and regulatory agencies, and reliance on intellectual property.",1.0,0.26043908913562025,0.0
How does the company plan to address the risk of failing to obtain regulatory approval for its product candidates?,I don't know.,"The company plans to navigate the regulatory approval process by ensuring compliance with all necessary clinical trial designs, data submissions, and regulatory requirements. It also aims to maintain open communication with regulatory authorities to address any issues promptly.",1.0,0.27510874432195587,0.5
What are the potential impacts of clinical trial delays on the company's business?,"Clinical trial delays can negatively impact a company's business by extending the time to market, increasing development costs, and potentially losing first-mover advantage in the market. Delays may also affect investor confidence, impact stock prices, and hinder revenue generation from the product. Additionally, prolonged delays could lead to patent expiration or reduced market exclusivity, weakening competitive positioning.","Clinical trial delays could result in increased costs, delays in advancing product candidates, and potential loss of market opportunities, which could harm the company's competitive position and financial performance.",5.0,0.794486285301415,1.0
How does the company plan to manage the financial risk associated with the need for substantial additional funding?,I don't know.,"The company plans to manage this risk through a combination of public or private equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements, and other marketing or distribution arrangements to secure the necessary capital on acceptable terms.",1.0,0.19540397390006453,0.5
What are the potential consequences of material weaknesses in the company's internal control over financial reporting?,"The potential consequences of material weaknesses in a company's internal control over financial reporting include:

1. **Increased Risk of Misstatements**: There is a higher likelihood of material errors or fraud in financial statements due to inadequate controls.

2. **Loss of Investor Confidence**: Investors may lose trust in the accuracy and reliability of the company's financial reporting, potentially leading to a decline in stock price.

3. **Regulatory Scrutiny and Penalties**: Regulators such as the SEC may investigate the company, leading to fines, sanctions, or required remediation efforts.

4. **Auditor Qualifications or Adverse Opinions**: Auditors may issue a qualified opinion, adverse opinion, or disclaimer of opinion on the financial statements.

5. **Increased Audit Costs**: The company may face higher audit fees due to the need for additional testing and remediation efforts.

6. **Operational Inefficiencies**: Weak internal controls can lead to inefficiencies in financial processes, increased risk of fraud, and potential legal liabilities.

7. **Reputational Damage**: Public disclosure of material weaknesses can harm the company's reputation with stakeholders, including customers, suppliers, and partners.

8. **Delisting Risk**: In severe cases, a company may face delisting from stock exchanges if it fails to remediate the weaknesses and maintain effective controls.","Material weaknesses could lead to a failure to maintain compliance with securities law requirements, loss of investor confidence, and a decline in the company's share price. It could also result in investigations by regulatory authorities.",5.0,0.7016782908761445,1.0
"What was the total purchase price for the acquisition of eNett and Optal by WEX Inc., and how was this amount allocated?",I don't know.,"The total purchase price for the acquisition of eNett and Optal by WEX Inc. was $577.5 million. This amount was allocated to the acquired businesses based on their estimated fair value of $415 million, with the residual value of $162.5 million allocated to the legal settlement.",1.0,0.21526377052471263,0.5
What measures did WEX Inc. take in response to the COVID-19 pandemic to safeguard its business and employees?,"WEX Inc. implemented several measures in response to the COVID-19 pandemic to safeguard its business and employees. These included transitioning to remote work for most employees to ensure safety, enhancing digital and cybersecurity infrastructure to support remote operations, and maintaining business continuity through robust operational and IT systems. The company also provided support for employee well-being, including access to mental health resources and flexible work arrangements. Additionally, WEX prioritized the health and safety of essential employees, offering protective equipment and implementing hygiene protocols where necessary.","WEX Inc. took several precautionary measures in response to the COVID-19 pandemic, including restricting business travel, temporarily closing offices, canceling participation in industry events, permanently reducing headcount, and furloughing employees across worldwide offices where necessary.",4.0,0.8033134736973954,1.0
What is the primary focus of the company's business?,I don't know.,The company is a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer by offering better and more durable benefits than currently available immuno-oncology treatments.,1.0,0.26451930773446125,0.5
What are the main product candidates currently under development by the company?,I don't know.,"The main product candidates are FS118, a tetravalent mAb2 bispecific antibody targeting PD-L1 and LAG-3; FS120, a dual agonist bispecific antibody stimulating CD137 and OX40; FS222, a bispecific antibody targeting CD137 and PD-L1; and SB 11285, a next-generation cyclic dinucleotide-based STING agonist.",1.0,0.18424177321814184,0.5
What are the key challenges and competitive landscape for the company's immuno-oncology therapies?,I don't know.,"The company faces potential competition from many sources, including large biotechnology and pharmaceutical companies, academic institutions, government agencies, and other public and private research organizations. The immuno-oncology field is characterized by rapidly advancing technologies and innovation, intense competition, and a strong emphasis on intellectual property.",1.0,0.24186570683194283,0.0
What are the regulatory requirements for marketing approval of the company's product candidates in the United States?,I don't know.,"The regulatory requirements include completing nonclinical laboratory tests and animal studies, submitting an Investigational New Drug (IND) application, conducting adequate and well-controlled human clinical trials, submitting a Biologics License Application (BLA) or New Drug Application (NDA), undergoing FDA pre-approval inspections of manufacturing facilities, and potential FDA audits of clinical trial sites.",1.0,0.27258370089533135,0.0
What are the potential environmental risks associated with the Partnership’s operations?,I don't know.,"The Partnership’s operations involve the generation, handling, and disposal of hazardous substances, hydrocarbons, and wastes, which are subject to stringent environmental laws and regulations. Non-compliance with these laws could result in significant penalties, remediation costs, and other liabilities.",1.0,0.22419056172626306,0.0
How does the Partnership’s reliance on key customers impact its financial results?,"The Partnership’s reliance on key customers can significantly impact its financial results because a substantial portion of its revenue may come from a limited number of customers. If one or more of these key customers reduce their orders, terminate their contracts, or experience financial difficulties, it could lead to a sharp decline in revenue, profitability, and cash flow. This dependence also limits pricing power and increases vulnerability to market fluctuations, potentially affecting the Partnership’s ability to achieve consistent growth and financial stability.",The Partnership’s intrastate and interstate transportation and storage operations depend on key customers to transport natural gas through its pipelines. The failure of these major shippers to fulfill their contractual obligations could have a material adverse effect on the Partnership’s cash flow and results of operations.,4.5,0.5688111889516368,1.0
What are the major types of revenue within the Partnership's reportable segments?,I don't know.,"The major types of revenue within the Partnership's reportable segments include intrastate transportation and storage, interstate transportation and storage, midstream, NGL and refined products transportation and services, crude oil transportation and services, investment in Sunoco LP, investment in USAC, and all other.",1.0,0.14227075146934876,0.0
"What is the total amount of long-term debt as of December 31, 2020?",I don't know.,"The total amount of long-term debt as of December 31, 2020 was $51.37 billion.",1.0,0.2705234166835569,0.5
How does the Partnership determine the fair value of its financial assets and liabilities?,"The Partnership determines the fair value of its financial assets and liabilities using observable market data and valuation techniques that reflect the assumptions market participants would use in pricing an asset or liability. This includes methods such as quoted prices in active markets, discounted cash flow analysis, and other valuation models, depending on the nature of the asset or liability. Fair value measurements are categorized into a hierarchy based on the transparency and reliability of the inputs used.","The Partnership determines the fair value of its financial assets and liabilities by using the highest possible “level” of inputs, including observable quotes in an active market for identical assets and liabilities (Level 1), inputs observable for similar assets and liabilities (Level 2), and unobservable inputs (Level 3).",4.0,0.7736681581620111,1.0
What are the key risks related to the company's financial position as outlined in the financial report?,I don't know.,"The key risks related to the company's financial position include a history of losses, reliance on a limited number of significant clients, and the need for additional capital to support business growth.",1.0,0.22851809078538243,0.0
How does the company's dependence on a few large clients impact its financial stability?,"The company's dependence on a few large clients can significantly impact its financial stability. If these clients reduce their orders, negotiate lower prices, or cease doing business with the company, it can lead to a sharp decline in revenue. This concentration of revenue increases vulnerability to market fluctuations, economic downturns, or changes in the clients' business strategies. Additionally, it may limit the company's ability to negotiate favorable terms or invest in growth, as a large portion of its income is tied to a small number of customers. Overall, such dependence increases financial risk and reduces resilience.","The company's dependence on a few large clients, such as Anthem, exposes it to significant financial risk if any of these clients were to reduce their business or terminate their contracts, which could materially affect revenue and financial stability.",5.0,0.7407345293111732,1.0
What are the potential impacts of rapid technological changes on the company's business?,"Rapid technological changes can have several potential impacts on a company's business, including:

1. **Increased Competition**: New technologies can lower barriers to entry, enabling new competitors to enter the market quickly and challenge established businesses.

2. **Operational Efficiency**: Automation and advanced software can improve productivity, reduce costs, and enhance decision-making through better data analytics.

3. **Customer Expectations**: Customers increasingly expect personalized, fast, and seamless digital experiences, requiring companies to adapt their services and products accordingly.

4. **Disruption of Business Models**: Emerging technologies can render existing products or services obsolete, forcing companies to innovate or risk losing market share.

5. **Need for Talent and Skills Development**: Companies may need to invest in upskilling employees or hiring specialists in new technologies like AI, cybersecurity, or cloud computing.

6. **Increased Investment Needs**: Rapid technological adoption often requires significant capital for R&D, infrastructure upgrades, and digital transformation.

7. **Regulatory and Compliance Challenges**: New technologies may bring new legal and ethical considerations, such as data privacy concerns, requiring businesses to stay compliant.

8. **Opportunities for Growth**: Companies that embrace innovation can expand into new markets, create new products, or improve customer engagement.

Overall, while rapid technological change poses challenges, it also presents significant opportunities for growth and competitive advantage.","Rapid technological changes pose a risk of obsolescence for the company's current technology and services, requiring continuous investment in research and development to stay competitive and relevant in the market.",5.0,0.5484355604775402,1.0
What is the primary risk factor mentioned in the financial report regarding the legality of cannabis under U.S. federal law?,"The primary risk factor mentioned in the financial report regarding the legality of cannabis under U.S. federal law is the potential for changes in federal policy that could affect the business operations, access to banking services, and overall market stability.","The primary risk factor is that cannabis remains illegal under U.S. federal law, which could lead to enforcement actions by federal authorities and potentially harm the company's business operations and financial condition.",4.0,0.8803233976464507,1.0
What are the potential consequences if the company fails to comply with state regulations in the jurisdictions where it operates?,"The potential consequences of a company failing to comply with state regulations include fines, penalties, legal actions, suspension or revocation of business licenses, increased scrutiny from regulatory agencies, damage to the company's reputation, and potential loss of customers or business opportunities. In severe cases, non-compliance could lead to criminal charges against company executives or employees.","If the company fails to comply with state regulations, it could face sanctions including revocation or additional conditions on licenses, suspension or expulsion from markets, imposition of fines and censures, and potential material liabilities or revocation of licenses and permits.",4.5,0.835926624422776,1.0
What measures does the company take to mitigate the risk of security breaches and theft in its operations?,I don't know.,"The company has implemented security measures at its facilities and engages a security firm for the transport and movement of large amounts of cash and products, including escorting employees by armed guards when necessary.",1.0,0.2684875292208426,0.0
What are the potential impacts of a global economic slowdown or financial market disruptions on the company's business?,I don't know.,"A global economic slowdown or financial market disruptions could lead to decreased consumer spending, reduced demand for the company's products, increased competition, and potentially lower revenues and profitability.",1.0,0.2920722720371023,0.0
"What critical audit matter was identified in the audit of Evergy, Inc.'s financial statements?",I don't know.,"The critical audit matter identified was the impact of rate regulation on the financial statements, particularly related to the accounting for the economics of rate regulation which impacts multiple financial statement line items and disclosures. This matter involved especially challenging, subjective, or complex judgments due to the high degree of subjectivity involved in assessing the impact of future regulatory orders on the financial statements.",1.0,0.2628536673400186,0.0
"What are the key components of Evergy, Inc.'s property, plant, and equipment accounting?",I don't know.,"The key components of Evergy, Inc.'s property, plant, and equipment accounting include recording the value at cost, which includes contracted services, direct labor and materials, indirect charges for engineering and supervision, and an allowance for funds used during construction (AFUDC). Depreciation and amortization are computed using the straight-line method over the estimated lives of depreciable property based on rates approved by state regulatory authorities.",1.0,0.21703939121126098,0.0
"How does Evergy, Inc. account for nuclear plant decommissioning costs?","Evergy, Inc. accounts for nuclear plant decommissioning costs by recognizing these costs as part of the overall cost of the plant, which is then depreciated over the plant's useful life. The company follows accounting standards, such as those set by the Financial Accounting Standards Board (FASB), which require that the decommissioning costs be estimated and recorded as a liability in the period when the plant is placed in service. These costs are funded through accruals, typically through a trust fund, to ensure that funds are available to cover future decommissioning expenses. The amount of the liability is adjusted periodically based on updated cost estimates, inflation, and other factors.","Evergy, Inc. accounts for nuclear plant decommissioning costs by contributing to a tax-qualified trust fund to be used to decommission Wolf Creek. Related liabilities for decommissioning are included in asset retirement obligations (AROs) on the consolidated balance sheets. Differences between the decommissioning trust fund asset and the related ARO are recorded as a regulatory asset or liability, reflecting the authorized regulatory treatment and related regulatory accounting.",3.5,0.7644196392443449,1.0
How does reliance on third-party manufacturers impact our business?,"Reliance on third-party manufacturers can impact your business in several ways, including:

1. **Cost Efficiency**: Outsourcing production can reduce overhead costs related to manufacturing, such as labor, equipment, and facilities.

2. **Scalability**: Third-party manufacturers often offer flexible production capacities, allowing your business to scale quickly in response to demand.

3. **Focus on Core Activities**: By offloading production, your company can concentrate on core competencies like marketing, product development, and customer service.

4. **Supply Chain Risks**: Dependence on external partners introduces risks such as delays, quality inconsistencies, or disruptions due to their operational issues.

5. **Quality Control**: Maintaining consistent product quality may be challenging if oversight of the manufacturer’s processes is limited.

6. **Intellectual Property (IP) Concerns**: Sharing proprietary designs or processes with third parties may pose risks of IP theft or unauthorized replication.

7. **Dependency and Reduced Flexibility**: Over-reliance on a single manufacturer may limit your ability to switch suppliers or adapt quickly to market changes.

8. **Reputation Exposure**: The manufacturer’s performance directly affects your brand reputation—poor quality or delays can damage customer trust.

To mitigate these impacts, businesses often implement strong supplier agreements, regular audits, and contingency plans.","Reliance on third-party manufacturers increases the risk of supply disruptions, quality control issues, and potential delays in product development and commercialization, which could adversely affect our ability to generate revenue.",4.0,0.7551235713186087,1.0
"How does KemPharm, Inc. recognize revenue from contracts with customers?","KemPharm, Inc. recognizes revenue from contracts with customers in accordance with the revenue recognition standard (ASC 606), which requires the company to recognize revenue when it satisfies a performance obligation by transferring a promised good or service to a customer. The company identifies the contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to the performance obligations, and recognizes revenue when (or as) each performance obligation is satisfied. Revenue recognition is based on the transfer of control of the product to the customer, which typically occurs upon shipment or delivery, depending on the terms of the contract.","KemPharm recognizes revenue in accordance with ASC 606, which involves identifying performance obligations, determining the transaction price, allocating the transaction price to each performance obligation, and recognizing revenue when (or as) each performance obligation is satisfied.",5.0,0.8818401383944103,1.0
"How has KemPharm, Inc. addressed its liquidity concerns?",I don't know.,"After taking into account the underwritten public offering, debt restructuring with subsequent payoff, and warrant inducement transactions discussed in Note R, the Company's cash and cash equivalents as of the filing date are sufficient to fund the Company's operating expenses and capital expenditure requirements for at least one year from the date the financial statements are issued.",1.0,0.18754158878657562,1.0
What are the terms of the KP415 License Agreement with Commave Therapeutics SA?,I don't know.,"Under the KP415 License Agreement, KemPharm granted Commave an exclusive, worldwide license to develop, manufacture, and commercialize the Company’s product candidates containing serdexmethylphenidate (SDX) and d-methylphenidate (d-MPH), including AZSTARYS, KP484, and optionally KP879, KP922, or any other product candidate developed by the Company containing SDX and developed to treat ADHD or any other central nervous system disorder. Commave paid an upfront payment of $10.0 million and agreed to pay milestone payments, sales milestones, and tiered royalty payments on net sales.",1.0,0.20621169369767925,1.0
What was the outcome of the debt restructuring mentioned in the financial report?,I don't know.,"In anticipation of the Public Offering, the Company restructured the December 2019 Notes and the January 2020 Note in the aggregate principal amount of $60.8 million and the Deerfield Note in the principal amount of $7.5 million. The Company exchanged $31.5 million of the outstanding principal and accrued interest on the Facility Notes for Series B-2 Preferred Stock and Exchange Warrants and made a payment of $30.3 million in partial repayment of the remaining outstanding principal and accrued interest on the Facility Notes.",1.0,0.1858588449900907,0.5
What is the role of the Dividend Retention Fund in Chubb's operations?,I don't know.,"The Dividend Retention Fund is used to maintain the statutory capital and surplus of Century Indemnity Company, a subsidiary of Chubb, by replenishing the principal to $50 million from dividends withheld from Chubb Group Holdings.",1.0,0.25848419380522336,0.0
How does Chubb manage its foreign currency exposure?,"Chubb manages its foreign currency exposure through a combination of natural hedging, operational strategies, and financial instruments. The company uses hedging strategies such as forward contracts, options, and other derivative instruments to mitigate the impact of exchange rate fluctuations on its earnings and cash flows. Additionally, Chubb employs a centralized treasury function to monitor and manage currency risk globally, ensuring that its hedging activities align with its overall risk management framework. These measures help Chubb maintain stability in its financial performance amid global currency volatility.","Chubb manages its foreign currency exposure by using foreign currency forward contracts to exchange specific currencies at a future date, aiming to minimize the effect of fluctuating foreign currencies.",4.5,0.8181808201893527,1.0
What is the impact of the COVID-19 pandemic on Chubb's unpaid losses and loss expenses in 2020?,I don't know.,"The COVID-19 pandemic led to an increase in Chubb's unpaid losses and loss expenses in 2020, primarily due to catastrophe losses incurred.",1.0,0.30083303761593266,0.0
What is the policy for dividend distributions from Chubb Limited?,I don't know.,"Chubb Limited issues dividends without subjecting them to withholding tax by way of distributions from capital contribution reserves and payment out of free reserves, with dividends stated in Swiss francs but paid in U.S. dollars.",1.0,0.3531083136878407,0.5
What are the principal risk factors associated with investing in the company's securities?,I don't know.,"Investing in the company's securities involves a high degree of risk, including speculative and leveraged investments, potential loss of capital, regulatory restrictions, and exposure to market volatility.",1.0,0.34193984994956245,0.0
How does the company's business model depend on referral relationships with venture capital and private equity fund sponsors?,I don't know.,The company's business model significantly relies on strong referral relationships with venture capital and private equity fund sponsors to generate investment opportunities. The inability to maintain or develop these relationships could adversely affect the company's business.,1.0,0.25178746745434555,0.0
What are the regulatory risks the company faces as a Business Development Company (BDC)?,"As a Business Development Company (BDC), the company faces several regulatory risks, including:

1. **Compliance with the Investment Company Act of 1940**: BDCs are subject to the regulations of the Investment Company Act of 1940, which governs their operations, including asset composition, leverage limits, and reporting requirements. Failure to comply can result in penalties or丧失 of BDC status.

2. **Leverage Restrictions**: BDCs are limited in their use of debt. They cannot borrow more than the value of their net assets and must maintain a minimum asset coverage ratio (typically 200% of senior securities). Exceeding these limits can result in regulatory scrutiny or penalties.

3. **Investment Activity Limits**: BDCs must derive at least 70% of their gross income from dividends, interest, and other income related to loans to portfolio companies. Failure to meet this requirement can jeopardize their BDC status.

4. **Prohibition on Certain Activities**: BDCs are restricted from engaging in certain high-risk investments or activities, such as buying securities for speculative purposes. Violations can lead to enforcement actions.

5. **Public Reporting and Disclosure Requirements**: BDCs must file regular reports (e.g., Form N-2) with the SEC, ensuring accurate and timely disclosure. Failure to meet these requirements can result in fines or sanctions.

6. **Board Oversight and Conflicts of Interest**: The company must ensure its board of directors oversees operations and manages conflicts of interest, especially with affiliated parties. Regulatory authorities may scrutinize such relationships.

7. **Regulatory Changes**: Changes in federal or state regulations affecting BDCs, such as tax law changes or new securities regulations, can increase compliance burdens or alter business models.

8. **Capital and Liquidity Risks**: Regulatory requirements may mandate maintaining certain capital levels, which could limit flexibility or require additional fundraising efforts.

These risks require robust compliance programs and ongoing monitoring to avoid regulatory enforcement and maintain BDC status.","As a BDC, the company is subject to regulatory constraints that may affect its ability to raise additional capital, incur debt, and make certain investments. Non-compliance with BDC regulations could lead to loss of status or enforcement actions.",5.0,0.7613756054329196,1.0
How does the company's exposure to changes in interest rates affect its profitability?,I don't know.,"Changes in interest rates can impact the company's net investment income, as higher rates may increase borrowing costs and reduce the demand for loans, while lower rates may decrease yields on new investments.",1.0,0.2903481757909803,0.0
What is the nature of the Company's business and what types of companies does it primarily lend to?,I don't know.,"The Company is a specialty finance company focused on providing senior secured loans to high-growth, innovative venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries.",1.0,0.2387848421720253,0.0
"What is the Company's policy regarding the declaration and payment of dividends, and how does it affect its tax status?",I don't know.,"The Company's policy is to declare and pay dividends on a quarterly basis, ensuring that it distributes at least 90% of its investment company taxable income to maintain its RIC tax status. This avoids federal income tax on the distributed portion of its taxable income.",1.0,0.18232017120229663,0.0
"How does the Company manage its credit risk, and what measures are in place to mitigate potential losses?",I don't know.,"The Company manages its credit risk through rigorous credit assessment processes, including obtaining first priority security interests in portfolio companies' assets, which may include intellectual property. It also monitors portfolio companies' financial performance and market conditions to mitigate potential losses.",1.0,0.18065771454554527,0.0
What was the impact of the adoption of ASC 606 on the company's revenue recognition?,I don't know.,The adoption of ASC 606 accelerated the timing of recognition of a portion of original listing fees related to the New York Stock Exchange businesses and decelerated the timing of recognition of a portion of clearing fee revenues.,1.0,0.22061610638532678,0.0
How does the company account for stock-based compensation?,I don't know.,"The company measures and recognizes compensation expense for share-based payment awards, including employee stock options, restricted stock, and shares purchased under the Employee Stock Purchase Plan, based on estimated fair values on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as stock-based compensation expense over the requisite service period.",1.0,0.24987210166376028,0.0
What is the primary function of the Exchanges segment?,I don't know.,"The Exchanges segment operates regulated marketplaces for the listing, trading, and clearing of a broad array of derivatives contracts and financial securities.",1.0,0.2001736637155011,0.0
What services does the Fixed Income and Data Services segment provide?,I don't know.,"This segment provides fixed income pricing, reference data, indices, execution services, global credit default swaps clearing, and multi-asset class data delivery solutions.",1.0,0.2577001355565859,0.0
What is the significance of the NYSE in the company's Exchanges segment?,"The NYSE (New York Stock Exchange) is a key component of the company's Exchanges segment, serving as a major global platform for trading equities, derivatives, and other financial instruments. It enhances the company's market presence, provides access to a large and diverse investor base, and contributes significantly to revenue through listing fees, trading activity, and related services. Its reputation for liquidity, transparency, and regulatory oversight strengthens the company's overall business and competitive position in the financial markets.","The NYSE is the global leader in listings, having been the venue of choice for innovators, visionaries, and leaders for over 225 years, and it is the leading listing venue across a range of sectors.",4.5,0.658488997028528,1.0
What measures have been taken to protect the company from clearing member defaults?,"To protect the company from clearing member defaults, measures such as margin requirements, netting, risk management systems, and default funds have been implemented. Clearing members are required to post initial and variation margins to cover potential losses. Additionally, the company may use collateral, daily mark-to-market settlements, and closeout procedures to mitigate risk. These mechanisms help ensure financial stability and protect other market participants from the impact of a defaulting member.",The company has contributed its own cash to the guaranty funds and added a layer of insurance to its clearing member default protection.,4.0,0.6743823485225192,1.0
How does the company's data services offerings aim to address market demands?,I don't know.,"The company's data services offerings aim to address the rising demand for independent, real-time information, which is being driven by regulation, market fragmentation, increasing technology and data demands, and passive investing and indexation.",1.0,0.19054723038425592,0.0
How does the company manage cybersecurity risks?,I don't know.,"The company employs a Cybersecurity Strategy (CSS) that emphasizes ongoing intelligence collection regarding cybersecurity threats and initiatives to address prominent areas of cybersecurity risk, including the deployment of external and internal teams of ethical hackers.",1.0,0.22992661549252588,0.5
How does the fair value determination of our portfolio investments impact our financial condition?,"The fair value determination of portfolio investments impacts our financial condition by influencing the reported value of those investments on our balance sheet, which in turn affects our equity, net income, and key financial ratios. Changes in fair value are typically recognized in earnings or other comprehensive income, depending on the classification of the investments (e.g., available-for-sale or trading securities). This can lead to volatility in reported profits and affect investor perceptions, credit ratings, and regulatory compliance. Additionally, fair value changes may trigger margin calls or affect capital adequacy ratios, particularly in institutions subject to regulatory oversight.","The fair value determination of our portfolio investments is subjective and dependent on a valuation process approved by our Board. Fair value fluctuations may cause our net asset value to materially understate or overstate the value we may ultimately realize on our investments, impacting our financial condition.",4.5,0.6502549113085929,1.0
How does the highly competitive market for investment opportunities affect our business?,"The highly competitive market for investment opportunities can impact our business by increasing pressure to offer attractive returns, innovate rapidly, and differentiate our offerings to attract investors. It may also lead to higher acquisition costs for assets or partnerships, and require more efficient capital allocation to remain competitive.","The highly competitive market for investment opportunities could reduce returns and result in losses as we may lose investment opportunities to competitors with greater financial, technical, and marketing resources. Competitors may also offer better pricing and more flexible structuring, forcing us to match their terms or forego opportunities.",4.0,0.7970513905438842,1.0
What measures are in place to manage the risk of material non-public information limiting our investment discretion in portfolio companies?,"To manage the risk of material non-public information (MNPI) limiting investment discretion in portfolio companies, firms typically implement a range of measures, including:

1. **Chinese Wall (Information Barrier) Policies**: Strict separation between teams handling public information and those with access to MNPI, ensuring that investment decisions are based on lawful and compliant data sources.

2. **Access Controls**: Limiting access to MNPI to authorized personnel only, with role-based permissions and audit trails.

3. **Compliance Training**: Regular training for employees on insider trading laws, MNPI handling, and ethical standards.

4. **Conflicts of Interest Policies**: Formal procedures to identify, disclose, and mitigate potential conflicts arising from access to MNPI.

5. **Trading Watches and Blackout Periods**: Prohibiting trading during periods when MNPI is likely to be discussed or material events are pending.

6. **Independent Investment Committees**: Involving disinterested parties in investment decisions to reduce bias and enhance oversight.

7. **Regular Audits and Monitoring**: Conducting periodic reviews to ensure compliance with internal policies and regulatory requirements.

These controls help ensure that investment decisions are made transparently, ethically, and in compliance with securities laws, thereby preserving investment discretion.","Members of our Investment Advisor’s investment committee and other investment professionals may serve as directors or in similar capacities in portfolio companies. If material non-public information is obtained, we could be prohibited from purchasing or selling securities of such companies, limiting our investment discretion.",4.5,0.5927458823884895,1.0
How does the involvement of interested directors in the valuation process create potential conflicts of interest?,"The involvement of interested directors in the valuation process creates potential conflicts of interest because they may have personal or financial stakes in the outcome of the valuation. For example, if a director owns shares in the company or has a vested interest in a specific transaction being evaluated, they might be inclined to influence the valuation to favor their own interests—such as maximizing the perceived value of their shares or supporting a transaction that benefits them personally. This can compromise their objectivity and lead to decisions that are not in the best interest of the company or its shareholders.","The involvement of interested directors in the valuation process could result in conflicts of interest as the Investment Advisor’s management fee is based on the value of our gross assets, and its incentive fees are based on realized and unrealized gains. This participation could influence the valuation process in a way that may not be in the best interest of all stockholders.",4.0,0.7547256516389862,1.0
What are the implications of the terms of the Investment Advisory Agreement and the Administration Agreement not being negotiated on an arm’s length basis?,"The implications of the terms of the Investment Advisory Agreement and the Administration Agreement not being negotiated on an arm’s length basis include potential conflicts of interest, reduced transparency, and possible regulatory scrutiny. Such arrangements may suggest that the parties are related or have a close relationship, which could lead to terms that are less favorable to the fund or its investors than those that would have been agreed upon between unrelated parties. This could affect the fairness of the fees and services provided, potentially undermining investor confidence and raising concerns with regulators regarding adherence to fiduciary duties and compliance with applicable laws and regulations.","The non-arm’s length negotiation of these agreements may result in terms that are not as favorable to us as if they had been negotiated with an unaffiliated third-party. This could include higher fees and less favorable incentive fee structures, which may induce the Investment Advisor to pursue speculative investments or use leverage when it may not be advisable.",4.0,0.7255989812776785,1.0
How does the potential for PIK interest payments affect our assets under management and the fees payable to Capitala Investment Advisors?,I don't know.,"PIK interest payments increase the size of the loan balance, thereby increasing our assets under management. This results in an increase in the base management fee payable to the Investment Advisor. Additionally, the accrual of interest on the higher loan balance increases our pre-incentive fee net investment income, leading to an increase in incentive fees.",1.0,0.2233078811720378,0.0
What are the primary risks associated with the commercial success of our products in the U.S.?,I don't know.,"The primary risks include the inability to meet sales expectations, attain profitability and positive cash-flow from operations, and the dependency on the effectiveness of sales, managed markets, marketing efforts, and support for our products.",1.0,0.2455409730641148,0.0
What are the potential consequences of failing to comply with cGMP regulations in our manufacturing processes?,"Failing to comply with cGMP (Current Good Manufacturing Practice) regulations can result in several serious consequences, including:

1. **Regulatory Actions**: The FDA or other regulatory agencies may issue warning letters, initiate inspections, or place a company on import alert, leading to product seizures or detention without entry.

2. **Product Recalls**: Non-compliant products may be recalled, damaging brand reputation and incurring significant financial costs.

3. **Fines and Penalties**: Companies may face substantial monetary penalties for violations of cGMP regulations.

4. **Legal Liability**: Failure to meet cGMP standards may expose the company to lawsuits, particularly if contaminated or defective products cause harm to consumers.

5. **Production Halts**: Regulatory agencies may issue ""notice of intent to seal"" or temporarily halt production until compliance is achieved.

6. **Loss of Market Access**: Inability to meet cGMP requirements can result in the loss of licenses or inability to sell products in regulated markets.

7. **Reputational Damage**: Publicized violations can erode consumer trust and impact long-term business success.

8. **Increased Scrutiny**: Repeated violations may lead to more frequent audits and heightened regulatory oversight.

Compliance with cGMP is essential to ensure product quality, safety, and effectiveness, and to maintain regulatory approval.","Failure to comply with cGMP regulations could result in product seizures, recalls, or withdrawals, suspension or withdrawal of marketing approvals, fines, and criminal prosecutions, which could significantly harm our business.",5.0,0.8659958586601411,1.0
What are the key provisions in our loan agreement that could restrict our operations?,I don't know.,"The loan agreement contains negative covenants that restrict our ability to sell or dispose of assets, amend certain material agreements, consolidate or merge, incur additional indebtedness, incur additional liens, pay dividends or make certain payments, and make payments of certain subordinated indebtedness.",1.0,0.2746722246293401,0.0
How does the classification of our board of directors into two classes affect our corporate governance?,"The classification of a board of directors into two classes typically affects corporate governance by staggering board elections, which can enhance board stability and continuity. This structure allows only a portion of the board to be elected at each annual meeting, reducing the risk of a complete board turnover and potentially insulating the board from short-term pressure or hostile takeovers. However, it may also limit shareholder influence in the governance process by making it more difficult to effect changes in board composition. This can impact the board's responsiveness to shareholder concerns and affect the balance of power between shareholders and directors.","The classification of our board of directors into two classes, with one class elected each year, may make it more difficult for a third party to acquire control of us or effect a change in our board of directors and management, potentially deterring hostile takeovers or changes in control.",5.0,0.6398740733825788,1.0
What are the potential impacts of Brexit on our international operations?,I don't know.,"Brexit could lead to legal uncertainty and divergent national laws and regulations, new regulatory costs and challenges, potential restrictions on direct investments by foreign entities and trade restrictions, and changes in tax laws and tariffs, which could adversely affect our operations.",1.0,0.2608503506378741,0.0
How does the company plan to manage the transition from a research and development focus to commercial activities?,I don't know.,"The company may encounter unforeseen expenses, difficulties, complications, delays, and other known and unknown obstacles during this transition. It may not be successful in this transition, which could adversely affect its business.",1.0,0.35223164388590816,0.5
What are the potential consequences if the company is unable to raise additional funding when needed?,"If the company is unable to raise additional funding when needed, it may face cash flow problems, inability to meet operational expenses, delayed product development, reduced ability to compete, potential layoffs, loss of key talent, and in severe cases, bankruptcy or liquidation.","If the company is unable to raise capital when needed, it could be forced to delay, reduce, or eliminate its product development programs or commercialization efforts, which would significantly impact its ability to develop and market its products.",5.0,0.7845720943921918,1.0
How does the company's reliance on third-party manufacturers impact its operations?,I don't know.,"The company's reliance on third-party manufacturers for the manufacture of its product candidates and related raw materials may expose it to risks such as unforeseen expenses, difficulties, complications, delays, and other known and unknown obstacles. If these third-party manufacturers fail to comply with regulatory requirements or meet contractual obligations, it could delay or prevent the company's ability to develop or commercialize its product candidates.",1.0,0.23433018048059467,0.0
What are the key risks related to the company's intellectual property?,I don't know.,"The key risks include the inability to obtain, maintain, or adequately protect intellectual property rights, potential infringement claims from third parties, and the uncertainty of patent litigation outcomes. Additionally, the company may face challenges in enforcing its patents and may not be able to prevent competitors from using similar technologies.",1.0,0.2711051687318614,0.0
What is the primary risk associated with investing in the company's common stock?,"The primary risk associated with investing in a company's common stock is the potential for loss of principal, as stock prices can fluctuate significantly due to market conditions, company performance, economic factors, and other risks. Shareholders also have residual claims, meaning they are paid only after creditors and preferred shareholders in the event of liquidation, which increases the risk of losing the entire investment.","Investing in the company's common stock involves a high degree of risk, including the potential for significant losses if the market price of the stock declines.",5.0,0.7817433664817715,1.0
What is the potential impact of the COVID-19 pandemic on the company's business?,I don't know.,"The COVID-19 pandemic has adversely impacted and may continue to adversely impact the company's business, including its preclinical studies and clinical trials, and finances, by causing disruptions in operations, delays in clinical trials, and financial market volatility.",1.0,0.24334831034754045,0.0
What are the risks related to the company's reliance on third-party manufacturers?,"The risks related to a company's reliance on third-party manufacturers include:

1. **Quality Control Issues**: The company may have limited control over the manufacturing process, leading to inconsistencies in product quality or defects.

2. **Supply Chain Disruptions**: Dependence on third-party manufacturers can make the company vulnerable to delays caused by the manufacturer's operational issues, natural disasters, or geopolitical events.

3. **Intellectual Property Risks**: Sharing proprietary designs or processes with third parties may lead to unauthorized replication or leakage of sensitive information.

4. **Reputation Damage**: Poor performance or unethical practices by a manufacturer (e.g., labor violations, environmental issues) can negatively impact the company's brand image.

5. **Cost Volatility**: The company may face unexpected increases in production costs due to changes in raw material prices, labor costs, or tariffs, especially if contracts are not properly managed.

6. **Lack of Flexibility**: The company may have limited ability to quickly adapt production schedules, scale up, or shift production in response to market demands.

7. **Regulatory Compliance Risks**: The manufacturer may fail to meet industry regulations or safety standards, exposing the company to legal penalties and product recalls.

8. **Geopolitical and Economic Risks**: Manufacturing in certain regions may expose the company to political instability, trade restrictions, or currency fluctuations.

9. **Dependency and Reduced Negotiating Power**: Over-reliance on a single or a few manufacturers can reduce the company's bargaining power, potentially leading to unfavorable terms.

10. **Cybersecurity Risks**: If the manufacturer uses connected systems or shares data, there may be risks of cyberattacks or data breaches affecting the company’s operations or customer information.","Risks include the potential for not having sufficient quantities of product candidates, failure of third-party manufacturers to comply with regulatory requirements, and the inability to control the quality and timeliness of manufacturing processes.",4.5,0.7201711486199741,1.0
What are the potential consequences of the company's inability to protect its intellectual property rights?,"The potential consequences of a company's inability to protect its intellectual property rights include loss of competitive advantage, reduced revenue due to unauthorized use or counterfeiting, damage to brand reputation, decreased investor confidence, and potential legal liabilities. Additionally, competitors may freely use proprietary technologies or creative works, undermining innovation and discouraging future investment in research and development.","Inability to protect intellectual property rights could lead to competitors developing and commercializing similar products, which could harm the company's business, financial condition, and competitive position.",5.0,0.7587647831921529,1.0
How does the company's reliance on third-party manufacturers impact its business operations?,"The company's reliance on third-party manufacturers can impact its business operations in several ways. It may lead to reduced control over production quality, supply chain delays, and increased dependency on external partners. This can affect product consistency, time-to-market, and overall operational efficiency. However, it also allows the company to reduce capital investment in manufacturing facilities and focus on core competencies like design, marketing, and distribution. The impact ultimately depends on the strength of supplier relationships, contractual agreements, and the company's ability to manage supply chain risks.","The company's reliance on third-party manufacturers for the production of its product candidates increases the risk of supply chain disruptions, quality control issues, and potential delays in the development and commercialization of its products.",4.5,0.670830449669002,1.0
How does the company's financial position and need for capital affect its ability to pursue its business objectives?,"A company's financial position and need for capital significantly affect its ability to pursue business objectives. A strong financial position—characterized by sufficient cash flow, low debt, and healthy profitability—enables the company to invest in growth, innovation, and strategic initiatives without relying heavily on external financing. This financial flexibility allows for quicker decision-making and the ability to seize market opportunities.

Conversely, a weak financial position or high need for capital can limit growth options, increase reliance on costly external funding, and lead to higher interest expenses or equity dilution. This can restrict investment in key areas such as R&D, marketing, or expansion, thereby hindering the company’s ability to achieve its business objectives. Additionally, financial constraints may force the company to prioritize short-term survival over long-term strategic goals.","The company's need for substantial additional funding to pursue its business objectives may limit its ability to conduct research and development, initiate clinical trials, and seek marketing approval for its product candidates, potentially delaying or preventing the achievement of its goals.",4.5,0.5390102311901688,1.0
What are the implications of the company's dual-class stock structure for minority shareholders?,"The implications of a company's dual-class stock structure for minority shareholders include reduced voting power, potential for managerial entrenchment, and limited influence over corporate decisions. In such structures, certain classes of shares (often held by founders or insiders) carry significantly more voting rights than others, allowing control to be concentrated in the hands of a small group. This can lead to decisions that prioritize the interests of majority shareholders over minority shareholders, potentially affecting corporate governance, transparency, and accountability.","The dual-class stock structure may limit the ability of minority shareholders to influence corporate matters and could result in decisions that are not aligned with their best interests, as the majority of voting power is concentrated among a few significant stockholders.",5.0,0.8334441495848467,1.0
How does Prelude Therapeutics design its clinical trials?,I don't know.,Prelude Therapeutics designs its clinical trials to leverage the broad utility of its compounds with a focus on efficient regulatory pathways to enable potentially transformative medicines to quickly reach patients with high unmet medical need.,1.0,0.17320550349104824,0.0
How does Prelude Therapeutics protect its intellectual property?,"Prelude Therapeutics protects its intellectual property through a combination of patents, trademarks, and trade secrets. The company files patent applications to secure exclusive rights to its proprietary technologies, drug candidates, and therapeutic methods. These patents cover novel compounds, formulations, manufacturing processes, and therapeutic uses. Additionally, Prelude Therapeutics may use trademarks to protect its brand name and logo. The company also employs internal controls, confidentiality agreements, and non-disclosure measures to safeguard trade secrets and proprietary information. For specific details on their IP strategy, one would need to consult their publicly filed patent documents or official disclosures.","Prelude Therapeutics protects its intellectual property by seeking and maintaining patent protection for compositions of matter, methods of use, and other inventions important to its business. It also relies on know-how and continuing technological innovation to maintain its proprietary position.",4.5,0.7634258723924868,1.0
What was the primary reason for the decrease in income tax expense in 2020?,I don't know.,"The decrease in income tax expense in 2020 was primarily due to the decrease in total income before tax, which was mainly caused by lower crude oil prices, partially offset by lower impairment and write-off charges.",1.0,0.18043225459534304,0.5
How did Chevron respond to market conditions and the COVID-19 pandemic during 2020?,"Chevron responded to market conditions and the COVID-19 pandemic in 2020 by implementing cost-cutting measures, reducing capital expenditures, and scaling back operations. The company suspended its dividend for the first time in over 100 years, laid off thousands of employees, and delayed or deferred major projects to preserve cash and manage financial risk amid plummeting oil prices and reduced global demand caused by pandemic-related lockdowns.","Chevron responded to market conditions and the COVID-19 pandemic by swiftly adjusting controllable items, such as lowering capital expenditures by 35% and reducing operating expenses by $1.4 billion compared to 2019. Additionally, the company suspended its stock repurchase program in March 2020 to protect the dividend and maintain a strong balance sheet.",3.0,0.9218006950986396,1.0
What were the key factors affecting Chevron's upstream segment earnings in 2020?,"In 2020, Chevron's upstream segment earnings were primarily affected by:  

1. **Declining oil prices** due to the COVID-19 pandemic, which led to reduced global demand and oversupply, causing a significant drop in Brent crude prices.  
2. **Production volumes** impacted by operational challenges, including maintenance and lower activity due to cost-cutting measures.  
3. **Asset impairments and write-downs** as a result of lower oil prices and long-term price forecasts, which reduced earnings.  
4. **Reduced exploration and development spending** in response to lower profitability and capital discipline.  
5. **Hedging activities**, which helped mitigate some of the price volatility but also limited upside from price recoveries.  

These factors collectively led to a substantial decline in upstream earnings compared to prior years.","The key factors affecting Chevron's upstream segment earnings in 2020 included lower crude oil and natural gas realizations, higher impairment and write-off charges, and lower crude oil sales volumes. These factors were influenced by external market conditions, including the impact of the COVID-19 pandemic and lower commodity prices.",4.5,0.8941117413442332,1.0
What were the major impairments and write-offs recorded by Chevron in 2020?,I don't know.,"In 2020, Chevron recorded major impairments and write-offs primarily due to downward revisions to its oil and gas price outlook. The company fully impaired its investments in Petropiar and Petroboscan in Venezuela, resulting in a total impairment of $2.6 billion.",1.0,0.20238544204095194,0.0
What was the impact of the Noble Energy acquisition on Chevron's financial position?,I don't know.,"The acquisition of Noble Energy added $7.7 billion in assets sales proceeds and increased Chevron's debt by assuming total debt, including finance lease obligations, with a fair value of approximately $9.4 billion. This acquisition provided Chevron with low-cost proved reserves and attractive undeveloped resources.",1.0,0.23014854567607843,0.0
What are the potential impacts of changes in tax laws or regulations on the company's financial condition?,"Changes in tax laws or regulations can significantly impact a company's financial condition by affecting its tax liabilities, cash flow, profitability, and overall financial planning. For example, an increase in corporate tax rates would reduce net income and retained earnings, while tax incentives or deductions could improve profitability and free up capital for investment. Additionally, changes may alter the timing of tax payments, impacting liquidity, and could influence strategic decisions such as capital expenditures, mergers and acquisitions, or international operations. Companies may also need to adjust their accounting practices and financial reporting to comply with new regulations.","Changes in tax laws or regulations, such as the Tax Cuts and Jobs Act of 2017 and the California Consumer Privacy Act (CCPA), could increase the company's compliance burdens and costs, potentially impacting its financial condition and results of operations.",4.5,0.591993507678763,1.0
"What is the current status of the Company's investment in Oak Therapeutics, Inc.?",I don't know.,"On April 15, 2019, the Company entered into a Termination and Release Agreement with Oak Therapeutics to surrender all of its Oak shares to Oak and terminate any rights the Company might have to acquire additional shares or interest in Oak. The parties terminated all contractual relationships between them. As of the date of deconsolidation, Oak had a negative net asset, which resulted in a gain of $0.08 million.",1.0,0.21349505899307142,0.5
How does the Company assess the recoverability of its long-lived assets?,"The Company assesses the recoverability of its long-lived assets by comparing the carrying amount of the assets to the estimated future undiscounted cash flows expected to be generated by those assets. If the carrying amount exceeds the estimated future cash flows, the asset is considered impaired, and an impairment loss is recognized.","The Company assesses the carrying value of its long-lived asset groups when indicators of impairment exist and recognizes an impairment loss when the carrying amount of a long-lived asset is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset. Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in the Company’s use of the assets or in its business strategy, loss of or changes in customer relationships, and significant negative industry or economic trends.",4.5,0.7682917130236648,1.0
How does our dependence on Merck for collaboration affect our business and financial condition?,I don't know.,"Our dependence on Merck involves risks such as Merck potentially not extending the research phase of the collaboration, deciding not to proceed with certain product candidates, or terminating the collaboration, which could delay or preclude our ability to complete research and development programs and materially adversely affect our business and financial condition.",1.0,0.2384685344716723,0.0
"What are the potential impacts of disease outbreaks, epidemics, and pandemics, such as COVID-19, on our business operations?","Disease outbreaks, epidemics, and pandemics like COVID-19 can significantly impact business operations by disrupting supply chains, reducing consumer demand, causing workforce shortages due to illness or quarantine measures, increasing operational costs, and forcing businesses to adapt to remote work or altered service delivery models. These events can also lead to economic downturns, decreased investment, and long-term shifts in consumer behavior, affecting profitability and strategic planning.","Disease outbreaks like COVID-19 can disrupt our operations, delay clinical trials, impact patient enrollment, and increase costs. They can also affect our ability to obtain regulatory approvals and commercialize our product candidates, thereby harming our business, financial condition, and results of operations.",4.5,0.6632741564229451,1.0
What are the risks associated with our international operations and expansion plans?,I don't know.,"Risks include compliance with varying regulatory requirements, potential difficulties in obtaining and maintaining regulatory approvals, challenges in managing foreign operations, and exposure to financial risks such as currency exchange rate fluctuations and longer payment cycles.",1.0,0.2562880241820615,0.0
What is the potential impact if the company fails to complete its initial business combination by the deadline?,"If the company fails to complete its initial business combination by the deadline, it may be required to liquidate and return the trust proceeds to public shareholders. This is a common provision in special purpose acquisition companies (SPACs), where the company must complete a business combination within a specified timeframe, typically two years from the closing of its initial public offering. Failure to do so results in the dissolution of the SPAC and the return of funds to investors, with no further obligation to complete a business combination.","If the company fails to complete its initial business combination by the deadline, it will cease all operations except for winding up, redeem public shares, and dissolve, resulting in shareholders receiving only their pro rata portion of the funds in the trust account, which may be less than $10.10 per share, and the warrants will expire worthless.",4.0,0.809961410386676,1.0
What are the key components of the decoupling mechanism for the Utilities?,I don't know.,"The key components of the decoupling mechanism for the Utilities include monthly revenue balancing account (RBA) revenues or refunds, rate adjustment mechanism (RAM) revenues, major project interim recovery (MPIR), performance incentive mechanisms (PIMs), and an earnings sharing mechanism (ESM).",1.0,0.1652649135708442,0.0
How does HEI manage its investment securities portfolio?,I don't know.,"HEI manages its investment securities portfolio by classifying investments as held-to-maturity (HTM), trading, or available-for-sale (AFS), and by using fair value estimates obtained from independent third-party pricing services or brokers.",1.0,0.23860886990659247,0.0
What is the significance of the performance-based regulation (PBR) framework approved by the PUC?,"The performance-based regulation (PBR) framework approved by the PUC is significant because it aligns utility incentives with public interests by rewarding utilities for achieving specific performance goals, such as reliability, efficiency, and customer satisfaction, rather than simply recovering costs based on traditional cost-of-service models. This encourages innovation, operational efficiency, and investment in modern infrastructure while protecting consumers from excessive rates.","The PBR framework approved by the PUC provides a new regulatory model that aims to provide financial stability to the Utilities and facilitate the transition to a clean energy economy. It includes mechanisms such as the annual revenue adjustment (ARA), earnings sharing mechanism (ESM), and performance incentive mechanisms (PIMs) to ensure efficient and effective operations.",4.5,0.8096086055766294,1.0
How does HEI manage its short-term borrowings?,I don't know.,"HEI manages its short-term borrowings through commercial paper and bank term loans. As of December 31, 2020, HEI had $65 million of commercial paper outstanding and a $65 million 364-day term loan from a syndicate of two banks. HEI also maintains credit facilities to support its short-term commercial paper program and working capital needs.",1.0,0.2529913524356838,0.0
How does HEI manage its long-term debt?,I don't know.,HEI manages its long-term debt by issuing unsecured senior notes through private placements and maintaining credit facilities to support its short-term commercial paper program and working capital needs. HEI also ensures compliance with financial covenants and customary conditions in its debt agreements.,1.0,0.1982251510495506,0.0
What are the unique properties of CSN therapeutics?,I don't know.,"CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystalline form, possess unusually high, unique catalytic activities not present in those same elements in bulk form. These nanocatalytic activities drive, support, and maintain beneficial metabolic and energetic intercellular reactions within diseased, stressed, and damaged cells.",1.0,0.2104819131556972,0.0
What is the patent-protected position of Clene?,I don't know.,Clene's patent-protected position affords it the potential to develop a broad and deep pipeline of novel CSN therapeutics to address a range of diseases with high impact on human health.,1.0,0.1644299093638659,1.0
What is the Clene Approach to drug development?,I don't know.,"The Clene approach to drug development is innovation-focused and scientifically driven, involving the creation of highly active therapeutic nanocatalysts with novel mechanisms of action resulting from proprietary advances in nanotechnology, plasma and quantum physics, biochemistry, and materials science.",1.0,0.21677198143734158,0.0
What is the market opportunity for CSN therapeutics in neurodegenerative diseases?,I don't know.,"Despite the urgent demand for treatments and the tremendous market opportunities for neurodegenerative disease therapeutics, effective treatments are limited. If the clinical studies underway provide evidence of remyelination or demonstrate improved neurological function, CSN therapeutics will have significant commercial sales potential in treating MS, PD, or ALS.",1.0,0.19057593453683266,0.0
What is the primary responsibility of the management of the Federal Home Loan Bank of Boston regarding internal control over financial reporting?,"The primary responsibility of the management of the Federal Home Loan Bank of Boston regarding internal control over financial reporting is to establish and maintain effective internal control over financial reporting to ensure the reliability of financial reporting and the preparation of financial statements in accordance with Generally Accepted Accounting Principles (GAAP). This includes designing, implementing, and monitoring processes to provide reasonable assurance regarding the accuracy and completeness of financial records and disclosures.",The management of the Federal Home Loan Bank of Boston is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.,5.0,0.8736584873672398,1.0
How does the Federal Home Loan Bank of Boston manage its credit risk exposure from advances?,"The Federal Home Loan Bank of Boston manages its credit risk exposure from advances through a combination of credit risk assessment, collateral requirements, and risk mitigation strategies. Advances are typically secured by high-quality collateral, such as mortgage loans, U.S. Treasury securities, and other eligible assets, which are subject to strict eligibility criteria and monitoring. The Bank also employs credit risk models and stress testing to evaluate the creditworthiness of its members and to ensure that collateral values are sufficient to cover potential losses. Additionally, the Bank maintains a capital structure and risk-based capital ratios to absorb potential losses and maintains liquidity reserves to manage financial stress. The Bank's credit risk management practices are guided by regulatory requirements and internal risk management policies.","The Federal Home Loan Bank of Boston manages its credit risk exposure from advances through an integrated approach that includes establishing credit limits for each borrower, ongoing review of each borrower's financial condition, and collateral and lending policies that limit risk of loss while balancing borrowers' needs for a reliable source of funding.",4.5,0.711041126163415,1.0
What are the key features of the Mortgage Partnership Finance® (MPF®) program through which the Federal Home Loan Bank of Boston invests in mortgage loans?,"The Mortgage Partnership Finance® (MPF®) program, administered by the Federal Home Loan Bank of Boston, enables participating financial institutions to sell qualifying mortgage loans to the Bank. Key features include:

1. **Loan Quality Standards**: The program specifies underwriting criteria for eligible loans, ensuring they meet credit and risk standards.
2. **Conforming Loan Limits**: Loans must conform to Fannie Mae and Freddie Mac guidelines, including loan size limits.
3. **Partnership Model**: Financial institutions (known as Partners) originate and service loans, then sell them to the Federal Home Loan Bank of Boston under the MPF® program.
4. **Risk Retention**: Partners retain a portion of the credit risk, typically through a risk-sharing mechanism such as a forward commitment or risk-sharing agreement.
5. **Funding and Liquidity**: The program provides participating institutions with liquidity and funding by purchasing loans, helping them support their lending activities.
6. **Loan Types**: The program typically includes fixed-rate, 30-year conventional mortgage loans, though other loan types may be eligible under certain conditions.
7. **Serviceability**: Loans must be serviced or the servicing must be transferred in a manner compliant with MPF® guidelines.
8. **Technology and Reporting**: The MPF® program uses a web-based platform for loan submission, tracking, and reporting to ensure compliance and transparency.

The MPF® program supports the Bank’s mission of promoting affordable housing and community development.",The MPF program allows the Federal Home Loan Bank of Boston to invest in conventional and government-insured or -guaranteed residential fixed-rate mortgage loans purchased from participating financial institutions. These loans are either guaranteed or insured by federal agencies or credit-enhanced by the related entity that sold the loan.,4.5,0.718147293378507,1.0
How does the company's significant indebtedness affect its financial flexibility?,"The company's significant indebtedness reduces its financial flexibility by limiting its ability to obtain additional financing, increasing interest expenses, and constraining its capacity to invest in growth opportunities or respond to unexpected challenges. High debt levels often require a larger portion of cash flow to be used for debt service, leaving less available for operational needs or strategic initiatives.","Significant indebtedness increases the risk of loss, reduces cash available for distributions, and may limit the company's ability to refinance debt or pursue new investments, potentially affecting its financial condition and results of operations.",4.5,0.738280113846004,1.0
How does the lack of liquidity in the company's investments affect its business?,"The lack of liquidity in a company's investments can limit its ability to quickly convert assets into cash without significant loss in value. This can affect the business by reducing financial flexibility, making it harder to meet short-term obligations, respond to unexpected opportunities, or manage cash flow during economic downturns. It may also increase the risk of default on debts and reduce the company's ability to invest in growth initiatives.","The lack of liquidity in the company's investments makes it difficult to sell assets quickly if needed, which could limit its ability to respond to changes in economic conditions or meet financial obligations.",5.0,0.8252671518868142,1.0
"What was the outcome of Rayonier Inc.'s management assessment of internal control over financial reporting as of December 31, 2020?",I don't know.,"Based on their evaluation under the criteria set forth in the Internal Control - Integrated Framework, management concluded that their internal control over financial reporting was effective as of December 31, 2020.",1.0,0.2273821435717716,1.0
What are the inherent limitations of internal control over financial reporting?,"The inherent limitations of internal control over financial reporting include:

1. **Human Error**: Mistakes in judgment, carelessness, or misunderstandings can compromise controls.
2. **Management Override**: Senior management may bypass or override controls for personal gain or to manipulate financial results.
3. **Collusion**: Two or more individuals may work together to circumvent controls.
4. **Cost-Benefit Considerations**: Controls are designed to be cost-effective, which may limit their scope or comprehensiveness.
5. **Inherent Limitations of Procedures**: Even well-designed controls cannot prevent all errors or fraud due to the nature of business processes.

These limitations mean that internal control provides reasonable, but not absolute, assurance that financial reporting is reliable.","The inherent limitations of internal control over financial reporting include the possibility of misstatements due to error or fraud not being prevented or detected on a timely basis. Additionally, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.",4.5,0.8216083016782918,1.0
What are the reportable business segments of Rayonier Inc. after the merger with Pope Resources?,"After the merger with Pope Resources, Rayonier Inc. operates in two reportable business segments: 

1. **Timberlands** – This segment includes the company's timberland properties and the associated timber harvesting and land management activities.
2. **Real Estate** – This segment involves the sale of developed and undeveloped land, primarily in high-growth areas.

These segments reflect the company's core operations following the merger.","After the merger with Pope Resources, Rayonier Inc. operates in six reportable segments: Southern Timber, Pacific Northwest Timber, New Zealand Timber, Timber Funds, Real Estate, and Trading.",2.0,0.9099886217905663,1.0
What is the nature of the environmental remediation liabilities assumed by Rayonier Inc. in the merger with Pope Resources?,I don't know.,"In the merger with Pope Resources, Rayonier Inc. assumed environmental remediation liabilities related to potential liability associated with environmental contamination and Natural Resource Damages (NRD) in Port Gamble, Washington.",1.0,0.17594144880435306,0.0
How does Rayonier Inc. account for its investments in marketable equity securities?,"Rayonier Inc. accounts for its investments in marketable equity securities as trading securities, which are reported at fair value with changes in fair value recognized in earnings.","Rayonier Inc. accounts for its investments in marketable equity securities at fair value based on quoted prices in their active market, with both the realized and unrealized gains and losses reported in “Interest and other miscellaneous income, net.”",4.0,0.8950779344094103,1.0
"What is the primary focus of Starwood Property Trust, Inc.?","The primary focus of Starwood Property Trust, Inc. is to provide financing for real estate assets, primarily through debt and structured finance solutions. The company specializes in acquiring and managing a portfolio of senior loans and mezzanine loans secured by commercial real estate properties in the United States.","Starwood Property Trust, Inc. is primarily focused on originating, acquiring, financing, and managing mortgage loans and other real estate investments in both the United States and Europe.",4.0,0.8356145119654514,1.0
How has the adoption of Accounting Standards Codification Topic 326 affected the Company's accounting for expected credit losses?,I don't know.,"The adoption of ASC 326, effective January 1, 2020, changed the Company's method of accounting for expected credit losses to a current expected credit loss model (CECL), which requires the consideration of possible credit losses over the life of an instrument, as opposed to only upon the occurrence of a discrete loss event.",1.0,0.2626483549466897,0.0
How does the Company manage its exposure to interest rate risk?,I don't know.,"The Company manages its exposure to interest rate risk by using derivative financial instruments such as interest rate swaps, which are designed to economically hedge certain risks. These derivatives are not designated for hedge accounting and changes in their fair value are recorded in earnings.",1.0,0.2035298421816026,0.0
What is the significance of the fair value option election for certain financial assets and liabilities?,"The fair value option election allows entities to measure certain financial assets and liabilities at fair value, even if other accounting standards would otherwise require amortized cost measurement. The significance includes:

1. **Improved financial reporting alignment**: It can provide more relevant information by reflecting current market values, enhancing transparency and comparability in financial statements.

2. **Hedging effectiveness**: It enables better matching of changes in fair value of hedged items with the hedging instrument, improving hedge accounting effectiveness.

3. **Reduced accounting mismatch**: It helps eliminate mismatches between the measurement of assets and liabilities in hedging relationships, leading to more accurate financial reporting.

4. **Optionality and flexibility**: Entities can elect this option at initial recognition for eligible financial instruments, offering flexibility in financial reporting based on their needs.

5. **Increased volatility**: A potential downside is that it may lead to increased earnings volatility due to mark-to-market adjustments.

Overall, the fair value option enhances the relevance of financial statements but may impact the stability of reported earnings.","The fair value option election allows the Company to make an irrevocable election to measure certain eligible financial assets and liabilities at fair value. Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings, which helps to mitigate accounting mismatches between the carrying value of the instruments and the related assets and liabilities that the Company consolidates at fair value.",4.5,0.6767588249717612,1.0
How does the Company account for acquisitions of real estate with in-place leases?,"The Company accounts for acquisitions of real estate with in-place leases by allocating the purchase price to the tangible assets, identifiable intangible assets (such as above-market or below-market leases, tenant relationships, and lease commissions), and liabilities based on their fair values at the acquisition date. This allocation is typically determined using valuation techniques such as income approaches, market comparables, and cost approaches. The assets and liabilities are then recorded at their fair values on the balance sheet, and the acquisition is accounted for under the acquisition method in accordance with U.S. GAAP (ASC 805). Any excess of the purchase price over the fair value of net assets acquired is recorded as goodwill.","For acquisitions of real estate with in-place leases where substantially all of the fair value of the assets acquired is concentrated in either a single identifiable asset or group of similar identifiable assets, the Company applies the asset acquisition provisions of ASC 805, resulting in the acquired properties being recognized initially at their purchase price inclusive of acquisition costs.",4.0,0.7146379476646871,1.0
What is the Company's approach to managing credit risk in its investment portfolio?,I don't know.,"The Company manages credit risk by regularly evaluating the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral, the financial and operating capability of the borrower, and the overall economic environment. It utilizes third-party database services to provide industry losses as benchmarks for determining expected credit losses.",1.0,0.2423928217546343,0.0
How has Stifel Financial Corp. adopted new accounting standards for credit losses?,"Stifel Financial Corp. adopted the Current Expected Credit Loss (CECL) model, as required by the Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) 2016-13, which became effective for public business entities for fiscal years beginning after December 15, 2019, and for interim periods within those fiscal years. The CECL model requires financial institutions to recognize expected credit losses for financial instruments at the time of origination or acquisition, rather than waiting until a loss is probable. 

Stifel Financial Corp. implemented the CECL model as of January 1, 2020, and the adoption resulted in a cumulative effect adjustment to retained earnings, reflecting the change in accounting method. The company uses internal models to estimate expected credit losses based on relevant historical data, current conditions, and reasonable and supportable forecasts. This approach aligns with the company's risk management practices and provides a more forward-looking assessment of credit risk. The impact of the adoption was disclosed in the company's 2019 Annual Report on Form 10-K and subsequent filings.","Stifel Financial Corp. adopted the new accounting standard for credit losses on January 1, 2020, which requires the measurement of the allowance for credit losses to be based on management’s best estimate of lifetime expected credit losses inherent in the Company’s relevant financial assets.",5.0,0.7309326266352388,1.0
How does Stifel Financial Corp. manage its off-balance sheet credit risk?,"Stifel Financial Corp. manages its off-balance sheet credit risk through a combination of risk assessment, monitoring, and control processes. The company utilizes credit limits, collateral requirements, and ongoing credit monitoring for off-balance sheet commitments such as loan commitments and letters of credit. Stifel also employs internal credit policies and models to evaluate and mitigate potential credit exposures. These practices are designed to ensure that off-balance sheet credit risk remains within acceptable limits and is consistent with the firm’s risk appetite. For detailed information, refer to Stifel's annual reports or regulatory filings, such as the 10-K, which provide specifics on risk management frameworks and policies.","Stifel Financial Corp. manages its off-balance sheet credit risk through various strategies, including position and credit limits, continuous monitoring of collateral, requiring additional collateral when appropriate, and using interest rate derivative contracts to manage exposures arising from business activities.",4.5,0.8317684619186828,1.0
What are the key factors considered in the valuation of Stifel Financial Corp.'s financial instruments?,"The key factors considered in the valuation of Stifel Financial Corp.'s financial instruments include market interest rates, credit risk, liquidity, volatility, and the instrument's maturity. Additionally, the valuation process considers observable market data, such as quoted prices, benchmark yields, and pricing models like discounted cash flow analysis or option pricing models. Fair value assessments also incorporate management's judgment regarding the impact of market conditions and specific instrument characteristics.","The key factors considered in the valuation of Stifel Financial Corp.'s financial instruments include observable market prices, contractual terms, market parameters, credit ratings, and the value of underlying collateral. The valuation techniques used vary depending on the level of pricing observability.",4.0,0.9244721979062648,1.0
How does Stifel Financial Corp. report its quarterly financial information?,"Stifel Financial Corp. reports its quarterly financial information through press releases and filings with the U.S. Securities and Exchange Commission (SEC). Specifically, the company files Form 10-Q, which includes a detailed report of its financial performance for the quarter, along with unaudited financial statements. These filings are made available on the SEC's EDGAR database and on Stifel's investor relations website.","Stifel Financial Corp. reports its quarterly financial information in a summarized format, providing key financial metrics such as revenues, net income, and earnings per share for each quarter of the fiscal year.",5.0,0.8331828367818901,1.0
What is the primary method used to evaluate the effectiveness of the Partnership’s internal control over financial reporting?,"The primary method used to evaluate the effectiveness of the Partnership’s internal control over financial reporting is a formal assessment process, typically involving internal auditors and external auditors, based on established frameworks such as the Committee of Sponsoring Organizations of the Treadway Commission (COSO) framework. This assessment includes testing controls, evaluating design and operating effectiveness, and documenting findings. The external auditor then provides an opinion on the effectiveness of internal control over financial reporting.",The Partnership uses the framework set forth in the report entitled “Internal Control-Integrated Framework” (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).,4.0,0.5711664540524167,1.0
What is the purpose of the commercial paper program maintained by the Partnership?,I don't know.,"The commercial paper program allows the Partnership to issue up to $3.0 billion in privately placed, unsecured commercial paper notes, which are primarily used for short-term financing needs such as working capital.",1.0,0.23457731056086528,0.5
How does the Partnership allocate net income for partners’ capital presentation purposes?,"The Partnership allocates net income to partners based on the terms outlined in the partnership agreement. This typically involves distributing income according to agreed-upon profit-sharing ratios, which may be based on capital contributions, services provided, or other specified factors. The allocation is recorded in the partners’ capital accounts to reflect their respective shares of the partnership's earnings.",Net income is allocated 100% to common unitholders after giving effect to income allocations for cash distributions to Series A preferred unitholders and guaranteed payments attributable to Series B preferred unitholders.,2.5,0.632621915249004,1.0
"How did Loews Corporation assess the effectiveness of its internal control over financial reporting as of December 31, 2020?",I don't know.,Loews Corporation's management assessed the effectiveness of its internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control - Integrated Framework (2013).,1.0,0.26731788654861627,0.5
"What significant accounting changes did Loews Corporation adopt on January 1, 2020?",I don't know.,"On January 1, 2020, Loews Corporation adopted ASU 2016-13, ""Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,"" which required changes to the recognition of credit losses on financial instruments not accounted for at fair value through net income.",1.0,0.2611013901884776,0.0
How did the adoption of ASU 2016-13 affect Loews Corporation's financial statements?,I don't know.,"The adoption of ASU 2016-13 resulted in a $5 million decrease in Retained earnings, after tax and noncontrolling interests, and the establishment of an allowance for credit losses of $6 million for available-for-sale fixed maturity securities that were purchased with credit deterioration.",1.0,0.2239599262761778,0.0
"What was the impact of Diamond Offshore's deconsolidation on Loews Corporation's financial statements for the year ended December 31, 2020?",I don't know.,"The deconsolidation of Diamond Offshore resulted in the recognition of a loss of $1.2 billion ($957 million after tax) during the year ended December 31, 2020, which is reported within Investment gains (losses) on the Consolidated Statements of Operations.",1.0,0.279051354560159,0.0
How did Boardwalk Pipelines' acquisition of common units affect its financial position?,I don't know.,"Boardwalk Pipelines' acquisition of common units resulted in an increase to Additional paid-in capital of $658 million, an increase to deferred income tax liabilities of $213 million, and a decrease to AOCI of $29 million.",1.0,0.1869681199086046,0.0
What are the potential risks associated with relying on third-party manufacturers for the supply of our product candidates?,"Relying on third-party manufacturers for the supply of product candidates can pose several potential risks, including:

1. **Supply Chain Disruptions**: Third-party manufacturers may face production delays, capacity constraints, or disruptions due to natural disasters, geopolitical issues, or financial instability, leading to delays in product availability.

2. **Quality Control Issues**: If the manufacturer does not adhere to strict quality standards or regulatory requirements, it could result in defective or substandard products, potentially damaging the company’s reputation and leading to regulatory actions.

3. **Intellectual Property Risks**: Sharing proprietary processes or formulations with third-party manufacturers may expose sensitive intellectual property, increasing the risk of theft or unauthorized use.

4. **Regulatory Compliance Risks**: Failure of the manufacturer to comply with Good Manufacturing Practices (GMP) or other regulatory requirements can result in product recalls, regulatory fines, or delays in approval.

5. **Lack of Control**: The company may have limited control over production timelines, capacity, and operational efficiency, which could impact product launch schedules and market competitiveness.

6. **Dependency and Lack of Flexibility**: Over-reliance on a single manufacturer or a limited number of suppliers can create supply chain vulnerability and reduce the ability to pivot in response to market changes or demand fluctuations.

7. **Cost Uncertainty**: Third-party manufacturers may increase prices due to inflation, market conditions, or changes in their own cost structures, impacting the company’s margins and profitability.

8. **Reputational Risk**: Any issues related to product safety, quality, or delivery from a third-party manufacturer can directly affect the company’s brand and customer trust.

9. **Contractual and Legal Risks**: Disputes over contract terms, intellectual property rights, or liability for product defects can lead to legal battles and financial losses.

10. **Geopolitical and Logistical Challenges**: Manufacturing in certain regions may be subject to political instability, trade restrictions, or transportation challenges, affecting timely delivery.

Mitigating these risks typically involves conducting thorough due diligence, establishing strong contractual agreements, diversifying suppliers where feasible, and maintaining robust oversight and quality assurance programs.","Relying on third-party manufacturers exposes us to risks including potential delays in product supply, quality control issues, and dependency on the manufacturers' compliance with regulatory requirements. Any failure by these manufacturers could delay our product development and commercialization efforts.",5.0,0.8342860179255815,1.0
How does the COVID-19 pandemic potentially impact the company's business operations?,I don't know.,"The COVID-19 pandemic could have a material adverse impact on the company's business, financial condition, and results of operations, including disruptions to clinical trials, manufacturing, supply chain, and commercialization efforts, as well as potential delays in regulatory approvals and market introduction of products.",1.0,0.27040816087718184,0.0
How does the company's reliance on third-party manufacturers affect its operations?,I don't know.,"The company's reliance on third-party manufacturers for the production of octreotide capsules exposes it to risks such as potential supply disruptions, quality control issues, and regulatory compliance challenges. Any failure by these manufacturers to meet quality standards or regulatory requirements could delay product development and commercialization, leading to increased costs and potential loss of market opportunities.",1.0,0.15959642790278342,0.0
"What are the financial implications of the company's Revenue Interest Financing Agreement with Healthcare Royalty Partners IV, L.P.?",I don't know.,"The Revenue Interest Financing Agreement imposes significant financial obligations on the company, including tiered quarterly royalty payments based on product revenues, potential gross-up payments, and restrictions on incurring additional indebtedness. These obligations could limit the company's financial flexibility and increase its operating costs, potentially impacting its ability to invest in growth initiatives and maintain profitability.",1.0,0.12075817409225317,0.0
How does the company plan to address the risk of product liability lawsuits?,I don't know.,"The company maintains product liability insurance coverage to mitigate the financial impact of potential product liability claims. However, it recognizes that insurance coverage may not be sufficient to cover all costs and liabilities that could arise from such claims, and it may face significant legal expenses, reputational damage, and potential financial losses if it is unable to defend against or settle these claims successfully.",1.0,0.26476811794287397,0.5
How does the company's dependence on a limited group of suppliers and manufacturers impact its business?,"The company's dependence on a limited group of suppliers and manufacturers can increase supply chain risk, reduce negotiating power, and make the business more vulnerable to disruptions such as natural disasters, geopolitical issues, or quality problems. It may also limit innovation and flexibility in sourcing, potentially leading to higher costs or delays in production. However, strong relationships with key suppliers can also lead to better quality control, improved collaboration, and long-term cost savings.","The company may incur significant product development costs or experience material delivery delays if there is an interruption in supply from any one of these suppliers or manufacturers, which could materially impact sales of its products.",4.5,0.5400933991033677,1.0
"What are the implications of the company being a ""controlled company"" under Nasdaq rules?","Under Nasdaq rules, a ""controlled company"" is a company where more than 50% of the voting power is held by a single shareholder or a group of related shareholders. The implications include:

1. **Exemption from Certain Governance Requirements**: Controlled companies are exempt from Nasdaq's requirements related to board independence, including the requirement to have a majority of independent directors, the requirement to have an independent compensation committee, and the requirement to have an independent nominating/governance committee.

2. **Reduced Board Oversight**: Because the controlling shareholder can influence board decisions, the board may not be as independent in its oversight of management.

3. **Potential for Conflict of Interest**: The controlling shareholder may have interests that conflict with minority shareholders, potentially leading to decisions that favor the controlling party.

4. **Less Transparency and Accountability**: The exemption from certain governance standards may result in less transparency and reduced accountability to public investors.

5. **Investor Concerns**: Some investors may view controlled companies as riskier due to the concentration of power, which could affect stock valuation or investor confidence.

These exemptions are intended to reduce compliance burdens for companies that are controlled by a single entity or family, but they come with trade-offs in corporate governance.","As a controlled company, the company qualifies for exemptions from certain corporate governance requirements, which may limit the protections afforded to shareholders and could impact the company's stock price and trading volume.",5.0,0.7019215270815367,1.0
What is the primary risk factor mentioned regarding investment in the company's shares?,I don't know.,"The primary risk factor mentioned is that an investment in the company's shares involves a high degree of risk, and the occurrence of any of the risks listed could have a material adverse effect on the company's business, financial condition, results of operations, and future growth prospects.",1.0,0.30218719142665185,0.0
How has the COVID-19 pandemic impacted the company's business operations and clinical development timelines?,I don't know.,"The COVID-19 pandemic has affected the company's business operations and clinical development timelines by impacting patient recruitment, enrollment, and follow-up visits at clinical sites. Government orders and restrictions to control the spread of the disease have also caused delays and uncertainties in the company's operations.",1.0,0.28633078421065944,0.0
What measures has the company taken to protect its intellectual property rights?,I don't know.,"The company seeks to protect its intellectual property rights by filing patent applications in the United States and abroad, entering into confidentiality agreements with parties who have access to its proprietary information, and maintaining physical and electronic security of its information technology systems.",1.0,0.2686104491760994,0.0
What are the risks associated with the company's reliance on third-party manufacturers for the production of its product candidates?,I don't know.,"The risks include the inability to meet product specifications and quality requirements consistently, delays in obtaining sufficient manufacturing capacity, potential non-compliance with regulatory requirements, and the possibility of increased costs and operational challenges if the company needs to find alternative manufacturers.",1.0,0.24731211627077887,0.0
"What was the opinion of KPMG LLP on the Company's internal control over financial reporting as of December 31, 2020?",I don't know.,"In their opinion, KPMG LLP stated that the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO framework.",1.0,0.22890351721756189,1.0
How did the Company support its liquidity and capital resources during the crisis in March 2020?,I don't know.,The Company supported its liquidity and capital resources by issuing four series of senior notes totaling ¥57.0 billion and issuing $1.0 billion in senior notes through public debt offerings under its U.S. shelf registration statement. The Company also has available liquidity in its unsecured revolving credit facilities of $1.0 billion and ¥100.0 billion and currently has no borrowings under either of these facilities.,1.0,0.25291592082341174,0.0
What are the significant accounting policies of Aflac Incorporated?,"Aflac Incorporated's significant accounting policies include, but are not limited to:

1. **Revenue Recognition**: Premiums are recognized as revenue on a pro-rata basis over the contract period. For policies with a single premium, revenue is recognized at the time of policy issuance.  
2. **Investments**: Investments are classified as available-for-sale, and are carried at fair value with unrealized gains and losses reported in other comprehensive income.  
3. **Deferred Acquisition Costs**: These are capitalized and amortized in proportion to the recognition of premium revenue, consistent with the pattern of benefit delivery.  
4. **Reserves for Future Policy Benefits**: Calculated using actuarial methods, including assumptions about morbidity, mortality, lapses, and expenses.  
5. **Premiums Receivable**: Recorded at the gross amount due, net of estimated uncollectible amounts.  
6. **Goodwill and Intangible Assets**: Recognized at acquisition cost and tested for impairment annually or when indicators of impairment exist.  
7. **Income Taxes**: Accounted for using the asset and liability method, recognizing deferred tax assets and liabilities based on temporary differences.  
8. **Share-Based Compensation**: Recognized as compensation expense based on fair value, over the vesting period.  
9. **Fair Value Measurements**: Financial assets and liabilities are measured at fair value using observable and unobservable inputs, classified under a three-level hierarchy.  
10. **Reinsurance**: Assumes and cedes risks, with reinsurance assets and liabilities reported at the net amount after ceding.  

These policies are detailed in Aflac’s Annual Report and filings with the SEC. For full details, refer to the Notes to Consolidated Financial Statements in the company's most recent Form 10-K.","The significant accounting policies of Aflac Incorporated include foreign currency translation, insurance revenue and expense recognition, cash and cash equivalents, investments, deferred policy acquisition costs, goodwill, policy liabilities, reinsurance, income taxes, treasury stock, share-based compensation, earnings per share, and reclassifications.",5.0,0.8209297724592961,1.0
How does the Company account for foreign currency translation?,I don't know.,"The functional currency of Aflac Japan is the Japanese yen. The Company translates its yen-denominated financial statement accounts into U.S. dollars as follows: assets and liabilities are translated at end-of-period exchange rates, realized gains and losses on security transactions are translated at the exchange rate on the trade date, and other revenues, expenses, and cash flows are translated using average exchange rates for the period. The resulting currency translation adjustments are reported in accumulated other comprehensive income.",1.0,0.31046136621443987,0.0
What is the basis for KPMG LLP's opinion on the consolidated financial statements?,"KPMG LLP's opinion on the consolidated financial statements is based on an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (PCAOB). The audit involves obtaining reasonable assurance that the financial statements are free of material misstatement, whether due to error or fraud, by performing procedures to assess the design and operating effectiveness of internal control relevant to the preparation and fair presentation of the consolidated financial statements in conformity with Generally Accepted Accounting Principles (GAAP).","KPMG LLP's opinion on the consolidated financial statements is based on their audits conducted in accordance with the standards of the PCAOB. Those standards require that they plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.",5.0,0.9431952480156919,1.0
How did the Company support its liquidity and capital resources during the crisis in March 2020?,I don't know.,The Company supported its liquidity and capital resources by issuing four series of senior notes totaling ¥57.0 billion and issuing $1.0 billion in senior notes through public debt offerings under its U.S. shelf registration statement. The Company also has available liquidity in its unsecured revolving credit facilities of $1.0 billion and ¥100.0 billion and currently has no borrowings under either of these facilities.,1.0,0.25291592082341174,0.0
What are the significant accounting policies of Aflac Incorporated?,"Aflac Incorporated's significant accounting policies include:

1. **Revenue Recognition**: Revenue from insurance contracts is recognized as premium income over the term of the policy, net of any policyholder dividends or surrenders. For annuity products, revenue is recognized when the contract is issued or as benefits are provided.

2. **Insurance Contracts**: Aflac uses the earned method to recognize revenue and the incurred method to recognize expenses for its insurance products. This includes reserving for future policyholder benefits.

3. **Reserves for Future Policyholder Benefits**: These reserves are established to cover future obligations under insurance contracts and are based on actuarial assumptions about mortality, morbidity, lapses, expenses, and investment yields.

4. **Long-Term Care Insurance Benefits**: Reserves for long-term care benefits are calculated using an actuarial method that considers the expected cost of future care, adjusted for future policyholder behavior.

5. **Investments**: Investments are classified as available-for-sale and are carried at fair value with unrealized gains and losses recorded in other comprehensive income. Fair value is determined using observable market data.

6. **Derivatives and Hedging Activities**: Aflac uses derivative instruments to manage interest rate risk. These are recorded at fair value on the balance sheet, with changes in fair value recognized in earnings or other comprehensive income based on the hedge accounting treatment.

7. **Goodwill and Other Intangible Assets**: Goodwill is tested for impairment annually or when there is an indication of impairment. Other intangible assets are amortized over their estimated useful lives.

8. **Income Taxes**: Aflac uses the asset and liability method to account for income taxes, recognizing deferred tax assets and liabilities based on temporary differences between financial statement and tax bases of assets and liabilities.

9. **Fair Value Measurements**: Fair value is measured using observable inputs (Level 1) when available; otherwise, it uses other observable inputs (Level 2) or unobservable inputs (Level 3).

10. **Reinsurance**: Aflac accounts for reinsurance contracts by recognizing reinsured amounts as a reduction of premiums and ceded claims, with reinsurance recoverables reported as assets.

For the most current and detailed information, refer to Aflac's most recent annual report or SEC filings.","The significant accounting policies of Aflac Incorporated include foreign currency translation, insurance revenue and expense recognition, cash and cash equivalents, investments, deferred policy acquisition costs, goodwill, policy liabilities, reinsurance, income taxes, treasury stock, share-based compensation, earnings per share, and reclassifications.",5.0,0.7821062948278107,1.0
How does the Company account for foreign currency translation?,I don't know.,"The functional currency of Aflac Japan is the Japanese yen. The Company translates its yen-denominated financial statement accounts into U.S. dollars as follows: assets and liabilities are translated at end-of-period exchange rates, realized gains and losses on security transactions are translated at the exchange rate on the trade date, and other revenues, expenses, and cash flows are translated using average exchange rates for the period. The resulting currency translation adjustments are reported in accumulated other comprehensive income.",1.0,0.31046136621443987,0.0
What was the outcome of the PJM Transmission Enhancement Settlement for DP&L?,I don't know.,"The PJM Transmission Enhancement Settlement resulted in a reduction of DP&L’s transmission costs through PJM, including credits to reimburse DP&L for amounts overcharged in prior years, which will be passed to customers through the TCRR.",1.0,0.14083316281182018,0.5
What was the impact of the adoption of ASC 326 on DP&L's financial statements in 2020?,I don't know.,"The adoption of ASC 326, which updates the impairment model for financial assets, did not have a material impact on DP&L's Consolidated Financial Statements in 2020.",1.0,0.2780854316344257,0.0
What methods were used to determine the fair value of the acquired intangible assets in the Caesars Entertainment Corporation acquisition?,I don't know.,"The fair value of acquired intangible assets was determined using various income approaches, including the relief from royalty method and excess earnings method.",1.0,0.18380168855162654,0.5
What were the key terms of the CEI Revolving Credit Facility?,I don't know.,"The CEI Revolving Credit Facility provided for a five-year senior secured revolving credit facility in an aggregate principal amount of $1.2 billion, with interest rates based on LIBOR or a base rate plus an applicable margin, and a commitment fee on unused commitments.",1.0,0.2314731807694298,0.0
How did the Company's annual goodwill and indefinite-lived intangible asset impairment analysis result in 2020?,I don't know.,"The Company recognized impairment charges in the Regional segment related to goodwill and trade names totaling $100 million and $16 million, respectively, due to declines in recent performance and the expected impact on future cash flows as a result of COVID-19.",1.0,0.226113285027436,0.0
What was the nature of the litigation involving Harrah’s New Orleans and the Department of Revenue?,I don't know.,"Harrah’s New Orleans was involved in litigation with the Department of Revenue related to sales taxes on hotel rooms, parking, and entertainment complimentaries for the periods from 2004 through 2016. The litigation is ongoing, and the Company has accrued contingent liabilities of $43 million as of December 31, 2020.",1.0,0.22101463912135255,0.0
What were the key terms of the Golf Course Use Agreement with VICI Properties L.P.?,I don't know.,"The Golf Course Use Agreement with VICI Properties L.P. provided for an annual payment of $10 million, an annual use fee of $3 million, and certain per-round fees, with a 35-year term inclusive of all renewal periods.",1.0,0.27446107693275146,0.0
What is the primary responsibility of Meredith management as stated in the financial report?,I don't know.,"Meredith management is responsible for the preparation, integrity, and objectivity of the financial information included in the Annual Report on Form 10-K for the year ended June 30, 2020.",1.0,0.23669461653773252,0.0
How are the consolidated financial statements of Meredith prepared?,I don't know.,The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include amounts based on informed judgments and estimates.,1.0,0.3377687903282266,0.5
Who audits the consolidated financial statements of Meredith Corporation?,I don't know.,The consolidated financial statements and the effectiveness of the Company’s internal control over financial reporting have been audited by an independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board (United States).,1.0,0.22289455302652003,0.5
How did the adoption of the new leasing standard affect Meredith's financial statements?,I don't know.,"Upon adoption, $509.9 million and $541.0 million were recorded for operating lease assets and liabilities, respectively, which included the impact to previously recorded liabilities associated with deferred rent and exit or disposal costs, and impairments of certain operating lease assets related to conditions that existed prior to adoption, which resulted in a decrease of $5.8 million to retained earnings as of July 1, 2019.",1.0,0.17176673927041075,0.0
"What was the total amount of long-term debt for Meredith Corporation as of June 30, 2020?",I don't know.,"The total amount of long-term debt for Meredith Corporation as of June 30, 2020, was $2.5 billion.",1.0,0.2199602271768446,1.0
"What was the total comprehensive income (loss) for Meredith Corporation for the year ended June 30, 2020?",I don't know.,"The total comprehensive income (loss) for Meredith Corporation for the year ended June 30, 2020, was a loss of $252.3 million.",1.0,0.24492144463564178,0.5
"What was the total amount of cash and cash equivalents for Meredith Corporation as of June 30, 2020?",I don't know.,"The total amount of cash and cash equivalents for Meredith Corporation as of June 30, 2020, was $122.3 million.",1.0,0.2303889705088509,0.5
"What is the primary objective of New York City REIT, Inc.'s use of derivative financial instruments?",I don't know.,"The primary objective of using derivative financial instruments is to hedge all or a portion of the interest rate risk associated with its borrowings, to minimize risks and costs associated with the Company’s operating and financial structure, and to hedge specific anticipated transactions.",1.0,0.18137034288474002,0.5
What measures did the Company take to address potential breaches of debt service coverage and debt yield covenants?,I don't know.,"The Company is currently in breach of a debt service coverage provision and a reserve fund reserve provision under its non-recourse mortgage secured by the 1140 Avenue of the Americas property, requiring excess cash to be held in a segregated account as additional collateral under the loan. The Company is also evaluating options under the loan pursuant to the contract and other alternative options associated with the property.",1.0,0.2540745182802957,0.0
"What accounting principle did i3 Verticals, Inc. adopt on October 1, 2019, and how did it affect revenue recognition?",I don't know.,"i3 Verticals, Inc. adopted Accounting Standards Codification Topic 606, ""Revenue from Contracts with Customers,"" which changed the timing of certain revenue and expenses recognition under various arrangement types. Revenue is now recognized as each performance obligation is satisfied, and more judgment and estimates are required when applying the requirements of the new standard.",1.0,0.28482511304040603,0.0
"How does i3 Verticals, Inc. account for the costs to obtain and fulfill a contract?",I don't know.,"i3 Verticals, Inc. capitalizes incremental costs to obtain new contracts and contract renewals and amortizes these costs on a straight-line basis as an expense over the benefit period, which is generally the contract term. These costs include commissions paid to obtain new sales.",1.0,0.2585389494407841,0.5
"What is the impact of the Tax Receivable Agreement (TRA) on i3 Verticals, Inc.'s financial position?",I don't know.,"The Tax Receivable Agreement (TRA) requires i3 Verticals, Inc. to pay 85% of certain tax benefits to the Continuing Equity Owners. This has resulted in the recognition of deferred tax assets and corresponding liabilities, which affect the company's financial position by increasing its deferred tax assets and liabilities.",1.0,0.18774673685127394,0.0
"What are the quarterly trends in i3 Verticals, Inc.'s revenue and net income for the years ended September 30, 2020 and 2019?",I don't know.,"For the year ended September 30, 2020, quarterly revenue trends showed an increase from $49,431 in Q1 to $57,606 in Q4, with net income ranging from $2,151 to $6,031. For the year ended September 30, 2019, quarterly revenue increased from $42,222 in Q1 to $50,851 in Q4, with net income ranging from $1,403 to $4,585.",1.0,0.1838770062262182,0.0
"How did the adoption of ASC 842 impact the Company's balance sheet as of April 1, 2019?",I don't know.,The adoption of ASC 842 resulted in the recording of $13.3 million of additional lease liabilities and right-of-use assets to the beginning balance of the Company’s Consolidated Balance Sheet.,1.0,0.17371689821690817,0.0
"What was the impact of the Redomestication on Global Indemnity Group, LLC's class A common shares?",I don't know.,"The Redomestication resulted in the shareholders of Global Indemnity Limited becoming the holders of all of the issued and outstanding common shares of Global Indemnity Group, LLC. The class A common shares of Global Indemnity Group, LLC began trading on Nasdaq under the symbol ""GBLI"" at the commencement of trading on August 28, 2020.",1.0,0.2923107983262341,0.5
What are the principal terms of the 7.875% Subordinated Notes due 2047 issued by Global Indemnity Limited?,I don't know.,"The principal terms of the 7.875% Subordinated Notes due 2047 include:
   - Annual interest rate of 7.875%, payable quarterly.
   - Maturity date of April 15, 2047.
   - The Company has the right to redeem the notes in whole or in part on or after April 15, 2022, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest.",1.0,0.1545946260367934,0.0
How is Berkshire Hathaway Energy's operations organized?,"Berkshire Hathaway Energy's operations are organized into several key business segments, including utility operations, transmission and distribution, and energy generation. The company operates through subsidiaries such as BHE Transmission, BHE Generation, and BHE Gas, each focusing on specific aspects of energy delivery and production. These segments collectively manage a wide range of energy assets across the United States and Canada.","BHE's operations are organized into eight business segments: PacifiCorp, MidAmerican Funding, NV Energy, Northern Powergrid, BHE Pipeline Group, BHE Transmission, BHE Renewables, and HomeServices.",3.0,0.6845233560085938,1.0
How many miles of transmission lines does BHE own?,I don't know.,"BHE owns approximately 36,000 miles of transmission lines.",1.0,0.2512132187129167,1.0
What is the total natural gas mains and service lines length for MidAmerican Energy?,I don't know.,"The natural gas distribution facilities of MidAmerican Energy included 24,100 miles of natural gas main and service lines as of December 31, 2020.",1.0,0.22292673899082122,0.5
How does NV Energy manage its energy supply function?,"NV Energy manages its energy supply function by operating and maintaining a diverse portfolio of power generation resources, including natural gas, solar, wind, and geothermal facilities. The company also engages in long-term contracts and power purchase agreements to secure additional energy. NV Energy integrates renewable energy sources into its grid, adheres to state regulations and renewable energy mandates, and uses advanced grid management systems to ensure reliability and efficiency. It works with regional transmission organizations and regulatory bodies to balance supply and demand, maintain grid stability, and meet customer needs.","NV Energy manages its energy supply function through four key components: IRPs, ESPs, DRPs, and action plans, which are filed with the PUCN for approval and operate in conjunction with the PUCN-approved 20-year IRP.",4.0,0.7247020368435854,1.0
What is the Emissions Reduction and Capacity Replacement Plan for Nevada Power?,I don't know.,"The ERCR Plan includes the retirement of 255 MWs of coal-fueled generation in 2019, acquisition of 536 MWs of natural gas generating resources, execution of long-term power purchase agreements for 200 MWs of nameplate renewable energy capacity, and construction of a 15-MW solar photovoltaic facility.",1.0,0.17071017747959452,0.5
What is the role of the Northern Powergrid Distribution Companies?,"The role of the Northern Powergrid Distribution Companies is to operate, maintain, and develop the electricity distribution network in their designated areas. This includes ensuring a reliable supply of electricity to homes, businesses, and other consumers, managing the infrastructure such as cables and transformers, responding to power outages, and connecting new properties to the grid. They work under regulation to ensure safe and efficient electricity distribution across their regions, primarily in northern England.","The Northern Powergrid Distribution Companies build, maintain, and operate the electricity distribution network through which end-users receive a supply of electricity. They charge fees for the use of their distribution systems to the suppliers of electricity.",5.0,0.8291628805620638,1.0
What is the market area design capacity of Northern Natural Gas?,I don't know.,Northern Natural Gas' pipeline system has a Market Area design capacity of 6.3 Bcf per day.,1.0,0.19372016890182853,0.5
What is the transmission system of the Nevada Utilities part of?,I don't know.,"The Nevada Utilities' transmission system is part of the Western Interconnection, a regional grid in the United States that includes the interconnected transmission systems of 14 western states, two Canadian provinces, and parts of Mexico.",1.0,0.263456236830297,1.0
What are the key components of the energy supply planning process for the Nevada Utilities?,I don't know.,"The key components are IRPs, ESPs, DRPs, and action plans, which are filed with the PUCN for approval and operate in conjunction with the PUCN-approved 20-year IRP.",1.0,0.199649667123487,0.0
What is the impact of California Senate Bill 100 on California's RPS?,"California Senate Bill 100 (SB 100), enacted in 2018, significantly strengthened California's Renewable Portfolio Standard (RPS) by setting a target of 100% carbon-free electricity by 2045. This legislation expanded the state's original RPS goal of 50% renewable energy by 2025, establishing a more ambitious and long-term commitment to clean energy. SB 100 also includes interim targets of 60% renewable energy by 2030 and a requirement that all in-state electricity generation be greenhouse gas-free by 2045. The bill has driven increased investment in renewable energy infrastructure, supported the growth of solar and wind power, and reinforced California's leadership in climate policy.","California Senate Bill 100 increased the RPS target to 60% by 2030 and enabled a longer-term planning target for 100% of total California retail sales to come from eligible renewable energy resources and zero-carbon resources by December 31, 2045.",5.0,0.6906880681468159,1.0
What is the role of the AESO in Alberta's electricity industry?,"The Alberta Electric System Operator (AESO) is responsible for ensuring the reliable and efficient operation of Alberta's electricity system. Its key roles include operating the power grid in real time, maintaining system reliability, managing the electricity market, and planning for future electricity supply and transmission needs. The AESO also oversees the dispatch of electricity generation to meet demand and ensures the safe and balanced operation of the grid.","The AESO's mandate is defined in the Electric Utilities Act (Alberta) and requires the AESO to assess both current and future needs of Alberta's interconnected electrical system. The AESO uses the 2019 Long-term Outlook, which is the AESO's forecast of Alberta's load and generation over the next 20 years, as one input to guide the AESO in planning Alberta's transmission system.",4.5,0.7630945731992164,1.0
What is the regulatory framework for BHE's regulated subsidiaries and certain affiliates?,I don't know.,"BHE's regulated subsidiaries and certain affiliates are subject to comprehensive governmental regulation, which significantly influences their operating environment, prices charged to customers, capital structure, costs, and ultimately their ability to recover costs and earn a reasonable return on invested capital.",1.0,0.23737351441537707,0.0
How has the COVID-19 pandemic affected the company's financial performance in 2020?,I don't know.,"The COVID-19 pandemic significantly impacted the company's financial performance in 2020, leading to a decrease in net income by $98.6 million or 35%, primarily due to a $107.9 million increase in the provision for credit losses and a $37.7 million decrease in net interest income.",1.0,0.26892206033666766,0.0
"How has the Hawaii economy been impacted by COVID-19, and what are the implications for the company?","The Hawaii economy has been significantly impacted by COVID-19, primarily due to the sharp decline in tourism, which is a major driver of the state's GDP. With international and domestic travel restrictions, hotel occupancy rates dropped, airlines reduced flights, and related sectors such as retail, hospitality, and transportation suffered major losses. The state also experienced job losses and a contraction in consumer spending. Additionally, government revenue declined due to reduced sales and tourism-related taxes, affecting public services and infrastructure spending.

For companies operating in Hawaii, especially those in tourism, hospitality, and retail, these conditions have led to reduced sales, cash flow challenges, and potential layoffs or business closures. Businesses reliant on tourists, such as tour operators and restaurants, faced prolonged periods of low demand. The pandemic also accelerated shifts toward remote work and digital services, which may create new opportunities for tech-focused companies but pose challenges for traditional in-person service providers.

The recovery has been gradual, with rebounding travel and vaccination rates improving economic conditions, but ongoing uncertainties, such as new variants and global travel disruptions, continue to pose risks. Companies must adapt to changing consumer behavior, enhance resilience, and possibly diversify their revenue streams to mitigate future shocks.","The Hawaii economy has been significantly impacted by COVID-19, with a 75.2% decrease in visitor arrivals and a 9.3% unemployment rate in December 2020. This has affected the company's operations and customer base, leading to increased credit risk and potential decreases in non-interest income.",4.5,0.6811679602832144,1.0
What are the key factors that could impact the company's profitability in future reporting periods?,I don't know.,"Key factors that could impact the company's profitability include continued adverse economic conditions due to the COVID-19 pandemic, changes in interest rates, increased credit risk, and potential decreases in non-interest income.",1.0,0.2687844347861613,0.0
How has the company's investment in high-grade investment securities evolved during 2020?,I don't know.,"The company increased its investment in high-grade investment securities, primarily collateralized mortgage obligations, with the total fair value of the investment securities portfolio rising by 49% to $6.1 billion as of December 31, 2020.",1.0,0.23785747852635114,0.0
"What is the primary purpose of the allowance for credit losses (ACL) at First Hawaiian, Inc.?","The primary purpose of the allowance for credit losses (ACL) at First Hawaiian, Inc. is to reflect the estimated losses inherent in the company's loan portfolio, ensuring that the financial statements accurately represent the potential credit risk. It serves as a reserve to absorb future loan losses and provides a more accurate picture of the bank's financial health.","The primary purpose of the ACL is to estimate and reserve for expected credit losses on loans and leases, ensuring that the net carrying value of these assets reflects the amount expected to be collected.",5.0,0.744295581813211,1.0
"How did the adoption of the Current Expected Credit Losses (CECL) model impact First Hawaiian, Inc.'s financial statements in 2020?","The adoption of the Current Expected Credit Losses (CECL) model in 2020 resulted in an increase in First Hawaiian, Inc.'s allowance for credit losses, which impacted its financial statements by recognizing expected credit losses upfront rather than waiting for losses to be incurred. This led to higher provisions for credit losses and, consequently, a reduction in net income and equity. The change also affected the reported loan portfolio and risk profile, providing a more forward-looking assessment of credit risk.","The adoption of CECL in 2020 required a cumulative effect adjustment to retained earnings as of January 1, 2020, reflecting changes in the allowance for credit losses and the reserve for unfunded commitments.",4.5,0.6101172687272033,1.0
"How does First Hawaiian, Inc. manage its interest rate risk?","First Hawaiian, Inc. manages its interest rate risk through a combination of asset and liability management strategies, including maintaining a balanced interest rate sensitivity position, utilizing financial instruments such as interest rate swaps and options, and monitoring and adjusting its portfolio to respond to changes in market conditions. The company also employs hedging strategies to mitigate the impact of interest rate fluctuations on its earnings and capital.","First Hawaiian, Inc. manages interest rate risk through the use of interest rate swaps designated as either fair value hedges or cash flow hedges, which help to offset potential adverse impacts on interest expense and net interest margin.",4.0,0.8736698974375093,1.0
"What was the impact of the Visa Class B restricted shares on First Hawaiian, Inc.'s financial statements in 2020?",I don't know.,"The Visa Class B restricted shares resulted in a revaluation adjustment, leading to losses in other noninterest income of $4.8 million in 2020, as the Company made monthly payments based on changes in Visa's conversion rate.",1.0,0.2649294291452156,0.0
"What are the regulatory capital requirements for First Hawaiian, Inc., and how did the company perform against these requirements as of December 31, 2020?","As of December 31, 2020, First Hawaiian, Inc. met the regulatory capital requirements set by the Federal Reserve and the Office of the Comptroller of the Currency (OCC). The company maintained capital ratios that exceeded the minimum requirements for a well-capitalized institution under the Basel III framework. Specifically, First Hawaiian, Inc. had a Tier 1 capital ratio, total capital ratio, and leverage ratio that were well above the required thresholds. These strong capital positions reflected the company’s financial stability and prudent risk management practices. For precise figures, refer to the company's 2020 annual report or regulatory filings.","First Hawaiian, Inc. is required to maintain minimum amounts and ratios of Common Equity Tier 1 (CET1) capital, Tier 1 capital, and total capital to risk-weighted assets, as well as a minimum leverage ratio. As of December 31, 2020, the Company was classified as well-capitalized and exceeded the capital conservation buffer.",4.0,0.8084803368534195,1.0
"What measures has First Hawaiian, Inc. taken in response to the COVID-19 pandemic, particularly concerning loan modifications and troubled debt restructurings (TDRs)?","First Hawaiian, Inc. implemented several measures in response to the COVID-19 pandemic, including loan modifications and troubled debt restructurings (TDRs). The company participated in federal relief programs such as the Paycheck Protection Program (PPP) and provided loan modifications to borrowers experiencing financial hardship. These modifications often included temporary forbearance, interest rate reductions, and payment deferrals. First Hawaiian also increased its provision for credit losses to account for potential loan losses stemming from the economic downturn. The bank followed accounting guidance to assess whether these modifications constituted TDRs, which required detailed analysis of borrower financial status and contract terms. Specific details about the extent of TDRs and modifications are typically disclosed in the company’s quarterly and annual reports filed with the SEC. For the most accurate and up-to-date information, refer to First Hawaiian, Inc.’s SEC filings.","In response to the COVID-19 pandemic, First Hawaiian, Inc. adopted provisions of the CARES Act and Interagency Statements, which allowed for temporary relief from TDR reporting for certain loan modifications made on a good faith basis in response to borrower impacts from COVID-19.",4.0,0.7310874064225016,1.0
What are the potential risks associated with the company's reliance on third-party manufacturers for Oxbryta and its product candidates?,I don't know.,"Risks include reliance on the third party for regulatory compliance and quality assurance, potential breach or termination of the manufacturing agreement, inability to satisfy ordering requirements as to quality, quantity, and price, and the unwillingness of the third party to extend or renew terms with the company.",1.0,0.234686579528132,0.0
How does the company plan to manage its intellectual property risks?,I don't know.,"The company seeks to protect its proprietary position by filing patent applications in the United States and abroad related to Oxbryta and its product candidates. However, it acknowledges the uncertainty and complexity involved in obtaining and enforcing biopharmaceutical patents.",1.0,0.2455793462857622,1.0
What are the potential risks associated with the company's international operations?,I don't know.,"Risks include compliance with complex and changing laws and regulations, difficulties in obtaining and maintaining regulatory approvals for sales or use of products in various countries, complexities in enforcing intellectual property rights, and financial risks such as longer payment cycles and exposure to foreign currency exchange rate fluctuations.",1.0,0.2652276659288221,0.0
What are the financial implications of the Orphan Drug Designation for Oxbryta in the United States?,"The Orphan Drug Designation for Oxbryta (voxelotor) in the United States provides several financial incentives to the manufacturer, including:

1. **Tax Credits**: The company is eligible for a tax credit of up to 50% of qualified clinical trial expenses incurred during the development of the drug.
2. **Expedited Review**: The drug qualifies for expedited review processes, which can reduce time to market and potentially increase revenue.
3. **Market Exclusivity**: The designation grants seven years of market exclusivity upon approval, preventing competitors from marketing the same drug for the same indication during that period.
4. **Fee Waivers**: The company is eligible for significant reductions or waivers of Prescription Drug User Fee Act (PDUFA) fees, reducing regulatory costs.

These incentives help offset the high costs associated with developing treatments for rare diseases, encouraging investment in therapies like Oxbryta for sickle cell disease.","The Orphan Drug Designation for Oxbryta in the United States provides several financial incentives, including tax credits for qualifying clinical trials, exemption from the PDUFA application fee, and a substantial period of regulatory market exclusivity, which will expire on November 25, 2026.",4.5,0.853314772374687,1.0
How does the company's dependence on a limited number of customers affect its operating results?,"The company's dependence on a limited number of customers can increase its risk and volatility in operating results. If one or a few customers significantly contribute to its revenue, a loss of business from any of these key customers—due to financial difficulties, changing needs, or switching to competitors—can lead to a sharp decline in sales and profitability. This concentration can also limit the company's pricing power and negotiating leverage, potentially leading to lower margins. Additionally, such dependence may affect investor confidence and the company's long-term sustainability.","The company's operating results are contingent on maintaining LNG, natural gas, steam, and power sales to these customers. The loss of a significant customer could adversely affect operating results.",4.5,0.5568791450615145,1.0
How does the company's limited operating history impact its ability to evaluate business prospects?,"A company's limited operating history makes it more difficult to evaluate business prospects because there is insufficient historical data to assess its ability to generate revenue, manage costs, and achieve profitability. This lack of track record reduces the reliability of financial forecasts and may increase the perceived risk for investors and stakeholders.","The limited operating history provides a less reliable basis for evaluating business prospects, as the company continues to develop policies and procedures and build its team.",4.5,0.8057599288209262,1.0
How did the acquisition of MBT Financial Corp. affect First Merchants Corporation's balance sheet?,I don't know.,"The acquisition of MBT Financial Corp. resulted in the addition of $98,563,000 of goodwill and $16,527,000 of core deposit intangibles to First Merchants Corporation's balance sheet.",1.0,0.2077000058845866,0.0
What are the key components of First Merchants Corporation's defined-benefit pension plans?,I don't know.,"The key components include service costs, interest costs, expected return on plan assets, amortization of prior service costs, and actuarial gains/losses.",1.0,0.21532949863462666,0.0
How does First Merchants Corporation manage its exposure to credit risk in financial instruments?,"First Merchants Corporation manages its exposure to credit risk in financial instruments through a combination of credit analysis, diversification, collateral requirements, and monitoring practices. The company assesses the creditworthiness of borrowers and counterparties, establishes credit limits, and regularly reviews credit exposures. Additionally, it may use credit risk mitigation techniques such as collateral, guarantees, and credit derivatives where appropriate. These practices are aligned with regulatory requirements and internal risk management policies to ensure prudent risk management.","First Merchants Corporation manages its exposure to credit risk by maintaining an allowance for loan losses, conducting regular credit quality reviews, and implementing credit policies and underwriting criteria for all loans.",4.5,0.8440129021954813,1.0
What is the primary purpose of the funds held in the trust account?,I don't know.,"The primary purpose of the funds held in the trust account is to be used for completing an initial business combination with a target business. If a business combination is not completed within the specified time frame, the funds are to be distributed to public stockholders.",1.0,0.23622344420770908,0.5
What are the potential risks associated with the ability of public stockholders to redeem their shares for cash?,"The potential risks associated with the ability of public stockholders to redeem their shares for cash include:

1. **Liquidity Risk**: If a large number of shareholders choose to redeem their shares simultaneously, the company may face significant cash outflows, potentially straining its liquidity position.

2. **Capital Structure Distortion**: Redeemable shares may alter the company’s capital structure, increasing debt or reducing equity, which can affect financial leverage and overall stability.

3. **Market Volatility**: The possibility of redemption can create uncertainty, leading to increased stock price volatility as investors react to redemption pressures.

4. **Reduced Investment Capacity**: Cash used for redemptions may be diverted from growth opportunities, research and development, or other strategic investments.

5. **Investor Perception**: Frequent redemptions may signal underlying concerns about the company's prospects, potentially deterring long-term investors.

6. **Management Distraction**: The need to manage redemption requests can divert management attention from core business operations.

7. **Regulatory and Compliance Costs**: Handling redemptions may involve additional legal, accounting, and reporting requirements, increasing operational complexity and costs.

8. **Oppressive Minority Practices**: In certain structures (e.g., special purpose acquisition companies), redemption rights may be used in ways that are unfavorable to minority shareholders.

These risks should be carefully managed through prudent financial planning and transparent governance practices.","The potential risks include making the company's financial condition unattractive to potential business combination targets, difficulty in entering into an initial business combination with a target, and the possibility of not meeting certain closing conditions if too many public stockholders exercise their redemption rights.",4.5,0.6589204880998325,1.0
What are the implications of the company being deemed an investment company under the Investment Company Act?,"If a company is deemed an investment company under the Investment Company Act of 1940, it is subject to extensive regulation, including requirements related to governance, operations, and disclosure. Key implications include:

1. **Regulatory Compliance**: The company must comply with the Act's provisions, which include restrictions on leverage, limitations on investments, and requirements for independent directors and auditors.

2. **Prohibited Activities**: Investment companies are generally prohibited from engaging in certain business activities, such as lending money or issuing senior securities, unless authorized.

3. **Transparency Requirements**: The company must file detailed reports with the SEC, provide regular financial statements, and offer shareholders a prospectus and annual reports.

4. **Restrictions on Structure**: The company must meet specific structural requirements, such as being managed by a board of directors and maintaining a certain level of diversification in its investments.

5. **Limitations on Management**: The Act restricts certain activities of investment companies, such as the ability to invest in other investment companies or engage in certain types of risk management strategies.

6. **Shareholder Protections**: The company must ensure that its operations are in the best interest of shareholders, with protections against conflicts of interest and improper conduct by management.

These regulations are designed to protect investors and ensure that investment companies operate in a transparent and sound manner.","If the company is deemed an investment company, it may be subject to burdensome compliance requirements, restrictions on the nature of its investments, and limitations on the issuance of securities, which could make it difficult to complete an initial business combination and could result in its liquidation.",4.5,0.6943598533025764,1.0
What is the primary responsibility of KeyCorp's management in relation to the financial statements?,"The primary responsibility of KeyCorp's management in relation to the financial statements is to prepare and present them fairly, in all material respects, in accordance with the applicable financial reporting framework, such as U.S. Generally Accepted Accounting Principles (GAAP). This includes ensuring the accuracy, completeness, and proper disclosure of financial information, as well as establishing and maintaining internal controls over financial reporting.","KeyCorp's management is responsible for the preparation, content, and integrity of the financial statements and other statistical data compiled for the annual report.",5.0,0.8467300273329426,1.0
What is the role of the Audit Committee in KeyCorp's financial reporting process?,"The Audit Committee of KeyCorp is responsible for overseeing the company's financial reporting process, internal control over financial reporting, and the independent audit process. It reviews the financial statements, monitors the independence and performance of the external auditor, and ensures that the company's financial disclosures are accurate and transparent. The committee also reviews risk management policies and investigates significant accounting issues.","The Audit Committee meets regularly with Management, internal audit, and the independent registered public accounting firm to review the scope of their audits and discuss the evaluation of internal accounting controls and financial reporting matters.",5.0,0.6632596613090124,1.0
How does KeyCorp assess the effectiveness of its internal control over financial reporting?,"KeyCorp assesses the effectiveness of its internal control over financial reporting through a comprehensive process that includes evaluating the design and operation of controls, testing their effectiveness, and documenting the results. This assessment is conducted annually by management, with oversight from the Audit Committee of the Board of Directors. The process involves internal control evaluations, risk assessments, and testing of key controls over financial reporting, as required by the Sarbanes-Oxley Act and SEC regulations. Additionally, KeyCorp engages independent auditors to provide an audit of the effectiveness of internal control over financial reporting, which is included in the company's annual report.","KeyCorp assesses the effectiveness of its internal control over financial reporting using criteria described in ""Internal Control - Integrated Framework"" issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework).",4.0,0.8038546245753461,1.0
What was the impact of adopting ASU 2016-13 on KeyCorp's financial statements?,I don't know.,"The adoption of ASU 2016-13 resulted in a $230 million decrease in retained earnings as of January 1, 2020, net of deferred taxes of $71 million, for the cumulative effect of adopting the new accounting standard for expected credit losses.",1.0,0.23362936649460306,0.0
What is the significance of the allowance for loan and lease losses (ALLL) in KeyCorp's financial statements?,"The allowance for loan and lease losses (ALLL) in KeyCorp's financial statements represents the amount of money the company has set aside to cover potential losses from loans and leases that may not be repaid. It is a critical indicator of the bank's financial health and risk management, reflecting its assessment of credit risk. A higher ALLL suggests greater perceived risk in the loan portfolio, while changes in the ALLL can impact the bank's earnings and capital adequacy. It is also used by regulators and investors to evaluate the bank's credit risk exposure and the prudence of its loan loss provisioning.","The ALLL represents KeyCorp's current estimate of lifetime credit losses inherent in the loan portfolio at the balance sheet date, which is a critical component in reflecting the expected credit losses in the financial statements.",5.0,0.7296827782008056,1.0
How does KeyCorp manage its exposure to credit risk on derivative contracts?,"KeyCorp manages its exposure to credit risk on derivative contracts through a combination of credit risk mitigation techniques, including collateral agreements, netting arrangements, and counterparty credit monitoring. The company typically requires collateral (such as cash or securities) from counterparties based on the exposure level, and uses master netting agreements to reduce the net exposure in the event of a default. Additionally, KeyCorp assesses the creditworthiness of counterparties and monitors their credit ratings and financial condition on an ongoing basis. These measures help limit potential losses in the event of a counterparty default.","KeyCorp mitigates credit risk on derivative contracts by entering into bilateral collateral and master netting agreements that allow for the net settlement of all contracts with a single counterparty in the event of default, and by monitoring counterparty credit risk exposure.",5.0,0.7689808821133117,1.0
What are the key components of KeyCorp's deferred tax assets and liabilities?,I don't know.,"KeyCorp's deferred tax assets and liabilities are determined based on temporary differences between financial statement asset and liability amounts and their respective tax bases, and are measured using enacted tax laws and rates expected to apply in the periods in which the deferred tax assets or liabilities are realized.",1.0,0.2889108609760452,0.0
How have the COVID-19 pandemic and government measures impacted the company's operations?,I don't know.,"The COVID-19 pandemic has caused disruptions in operations, including delays in clinical trials, difficulties in patient enrollment, and potential impact on the cost and timelines of the Phase 3 program.",1.0,0.3077496274718076,0.0
What are the potential risks associated with relying on third-party manufacturers for the production of ensifentrine?,"Relying on third-party manufacturers for the production of ensifentrine may pose several potential risks, including:

1. **Quality Control Issues**: Third-party manufacturers may not adhere to the same stringent quality standards as the original company, potentially leading to inconsistencies in drug potency, purity, or safety.

2. **Supply Chain Disruptions**: Dependence on external producers increases vulnerability to supply chain interruptions due to natural disasters, geopolitical issues, or financial instability of the manufacturer.

3. **Intellectual Property Risks**: Sharing manufacturing processes with third parties may expose proprietary formulations or production techniques, increasing the risk of IP theft or unauthorized replication.

4. **Regulatory Compliance**: If the third-party manufacturer fails to comply with regulatory standards (e.g., FDA, EMA), it could lead to product recalls, delays in approval, or legal repercussions.

5. **Limited Oversight**: Reduced direct control over production processes may hinder timely detection and resolution of manufacturing defects or deviations.

6. **Reputation Damage**: Any quality or safety issues arising from third-party production could damage the reputation of the parent company or brand.

7. **Cost Uncertainty**: Contract terms with third-party manufacturers may include hidden costs or price fluctuations, affecting overall production economics.

These risks underscore the importance of rigorous due diligence, strong contractual agreements, and ongoing monitoring when relying on third-party manufacturers.","Risks include potential delays in supply, quality control issues, and the possibility of third-party manufacturers failing to comply with regulatory requirements, which could delay or prevent the commercialization of ensifentrine.",5.0,0.7884223660177871,1.0
How did the COVID-19 pandemic affect South State Corporation's operations and financial results in 2020?,I don't know.,"The COVID-19 pandemic led to increased provisions for credit losses, changes in customer behavior affecting deposit and loan activities, and operational challenges such as branch closures and remote work setups, which collectively impacted financial results and operational efficiency in 2020.",1.0,0.27019993097463585,0.0
What measures did South State Corporation implement in response to the COVID-19 pandemic to support its customers and maintain operational continuity?,I don't know.,"South State Corporation implemented loan modification programs, payment deferrals, and fee waivers for affected customers. Internally, the bank closed banking lobbies, moved to drive-thru and online services, and allowed non-customer-facing employees to work from home to ensure operational continuity.",1.0,0.2731335179546955,0.0
"How did South State Corporation's capital adequacy ratios change post-merger with CSFL, and what factors influenced these changes?",I don't know.,"Post-merger, South State Corporation's capital ratios, particularly the Tier 1 leverage ratio and Tier 1 risk-based capital ratio, decreased due to the significant increase in assets and risk-weighted assets. However, the total risk-based capital ratio increased, influenced by the inclusion of additional Tier 2 capital from subordinated debt and trust preferred securities acquired through the merger.",1.0,0.1540334870254207,0.0
How did the merger with CenterState Bank Corporation (CSFL) impact South State Corporation's loan portfolio at the time of acquisition?,"The merger with CenterState Bank Corporation (CSFL) significantly expanded South State Corporation's loan portfolio at the time of acquisition. Specifically, the merger added approximately $4.5 billion in loans to South State's existing portfolio, enhancing its scale and market presence, particularly in Florida and the Southeast. This transaction strengthened South State's position as a regional bank with a larger lending footprint.","The merger with CSFL resulted in South State Corporation acquiring $13.0 billion of loans, including PPP loans, at fair value, net of $239.5 million, or 1.82%, estimated discount to the outstanding principal balance, representing 113.9% of the Company’s total loans at December 31, 2019.",2.0,0.7721182215277277,1.0
What was the impact of the COVID-19 pandemic on South State Corporation's evaluation of goodwill for impairment in 2020?,I don't know.,"South State Corporation evaluated the carrying value of goodwill as of April 30, 2020, considering the effects of COVID-19, and obtained a third-party valuation during the fourth quarter of 2020, concluding that no impairment charge was necessary.",1.0,0.2775701518188358,0.0
What are the potential consequences of the company's failure to maintain REIT qualification?,"The potential consequences of a company's failure to maintain REIT qualification include loss of tax advantages, imposition of corporate income taxes on income, potential retroactive penalties and interest, and possible loss of shareholder confidence. Additionally, the company may be required to restructure its operations or face the risk of termination or dissolution, depending on the severity and duration of the disqualification.","If the company fails to maintain its REIT qualification, it would be subject to corporate-level income taxes on all of its taxable income, which would significantly reduce the amount of cash available for distribution to shareholders. This could negatively affect the value of its common shares and the sustainability of its business model.",4.5,0.8103742087495104,1.0
How does the company mitigate interest rate risk and what are the potential drawbacks of its hedging strategies?,I don't know.,"The company uses derivative financial instruments, such as swaps, options, and futures, to hedge against interest rate risk. However, these hedging activities can be expensive, may not perfectly correlate with the risks being hedged, and could result in worse overall investment performance if unanticipated changes in interest rates occur.",1.0,0.26739789837486966,0.0
What are the cybersecurity risks the company faces and how could they impact its operations?,I don't know.,"The company faces risks of cyber incidents, including unauthorized access, data breaches, and system disruptions. These could lead to compromised confidential information, operational disruptions, financial losses, litigation, and damage to business relationships, all of which could negatively impact its financial results and reputation.",1.0,0.2780586335039891,0.0
"What is the primary investment objective of Barings BDC, Inc.?","The primary investment objective of Barings BDC, Inc. is to generate current income and potential capital appreciation by investing primarily in loans and other debt securities of U.S. middle-market companies.","The primary investment objective of Barings BDC, Inc. is to generate current income by investing directly in privately-held middle-market companies to help these companies fund acquisitions, growth, or refinancing.",4.0,0.9588828845762593,1.0
"What was the total amount of new commitments made by Barings BDC, Inc. subsequent to December 31, 2020?",I don't know.,"Subsequent to December 31, 2020, the Company made approximately $224.1 million of new commitments, of which $202.2 million closed and funded.",1.0,0.24700846195309215,1.0
How did the Company account for the COVID-19 pandemic in its financial statements?,I don't know.,"The Company temporarily closed its retail locations due to the COVID-19 pandemic, which it expects to have an unfavorable impact on its sales, results of operations, and cash flows in fiscal 2020.",1.0,0.2900196457457629,0.0
What was the impact of the adoption of the new lease accounting standard (ASUs) on the Company’s consolidated balance sheet?,I don't know.,"The adoption of the ASUs resulted in the recognition of lease right-of-use assets and corresponding lease liabilities, as well as adjustments to opening retained earnings and other balance sheet items.",1.0,0.20064559934771142,0.0
What were the key factors considered by the Company in determining the fair value of its reporting units for impairment testing?,I don't know.,"The Company considered factors such as revenues, expenses, fixed asset and working capital requirements, the impact of updated tax legislation, and other subjective inputs in determining the fair value of its reporting units.",1.0,0.16480805300679782,0.0
How has the COVID-19 pandemic impacted the company's operations and financial outlook for fiscal 2020?,I don't know.,"The COVID-19 pandemic has significantly disrupted the company's operations, leading to temporary store closures and substantial uncertainty about the timing and manner of returning to normal business operations. The company has withdrawn all prior guidance and outlook statements for fiscal 2020 due to the unpredictable nature of the pandemic's impact.",1.0,0.3228978281106575,0.0
What are the key strategies the company is focusing on to drive growth in its business?,I don't know.,"The company is focusing on several key strategies to drive growth, including transforming its real estate platform, pursuing international expansion, expanding its merchandise assortment and market share, growing its integrated hospitality experience, and architecting a new operating platform to enhance customer experience and operational efficiency.",1.0,0.2060559957779829,0.0
How does the company assess the performance of its business?,I don't know.,"The company assesses the performance of its business using various financial and operating measures, including net revenues, gross profit, selling, general, and administrative expenses, adjusted operating income, adjusted EBITDA, and adjusted net income. These measures help the company evaluate its operating performance consistently over time.",1.0,0.19544859172258966,0.0
"What are the company's primary sources of liquidity, and how has the COVID-19 crisis affected its liquidity position?",I don't know.,"The company's primary sources of liquidity are cash flows from operations, net cash proceeds from the issuance of convertible senior notes, and borrowings under its credit facilities. The COVID-19 crisis has introduced significant uncertainty regarding the company's liquidity requirements and has prompted the company to implement cost-saving measures and negotiate with lenders and landlords to preserve financial flexibility.",1.0,0.23537628164690405,0.0
"How has the company's approach to real estate transformation evolved, and what impact has it had on the business?",I don't know.,"The company has evolved its real estate approach by adopting a multi-tier market strategy, including the development of prototype Design Galleries, larger Bespoke Design Galleries in top metropolitan markets, indigenous Bespoke Galleries in second home markets, and smaller Galleries in secondary markets. This strategy aims to optimize market share and return on invested capital, with recent openings showing positive results in terms of profitability and brand statement.",1.0,0.11599925776619305,0.0
What are the risks associated with the company's reliance on third-party manufacturers for the production of its product candidates?,I don't know.,"The risks include potential delays in manufacturing, quality control issues, and the possibility of the third-party manufacturer failing to meet demand or terminating the relationship, which could impact the company's ability to supply its product candidates for clinical trials or commercialization.",1.0,0.253983739526617,0.0
What are the provisions in the company's corporate charter that could potentially discourage a takeover?,I don't know.,"The company's corporate charter includes provisions such as a classified board of directors, advance notice requirements for stockholder proposals, and a requirement for a supermajority vote to amend certain provisions, which could make a takeover more difficult.",1.0,0.28793939958298204,0.0
What is the significance of the company's exclusive forum provision in its certificate of incorporation?,"The significance of a company's exclusive forum provision in its certificate of incorporation is that it designates a specific court (such as the Delaware Court of Chancery) as the sole venue for resolving certain types of legal disputes, typically those related to corporate governance or internal affairs. This provision helps ensure legal predictability, reduces forum shopping, and can make it more efficient and cost-effective for the company and its directors to resolve disputes. It is often included in Delaware corporations due to the state's well-established and specialized body of corporate law.","The exclusive forum provision designates the Court of Chancery of the State of Delaware as the sole forum for certain types of actions and disputes between the company and its stockholders, which could limit stockholders' ability to choose a preferred judicial forum for such disputes.",5.0,0.7171665446306202,1.0
What are the potential financial and operational impacts of the company becoming involved in securities class action litigation?,"The potential financial and operational impacts of a company becoming involved in securities class action litigation include:

**Financial Impacts:**
- **Legal Costs:** Significant expenses related to hiring specialized litigation counsel, expert witnesses, and other legal fees.
- **Settlement or Judgment Payments:** The company may be required to pay substantial monetary damages or settlement amounts, which can strain financial resources.
- **Increased Insurance Premiums:** Costs for directors and officers (D&O) liability insurance may rise due to increased risk exposure.
- **Impact on Stock Price:** Litigation may lead to a decline in stock value due to investor concerns about the company's financial stability or governance.

**Operational Impacts:**
- **Management Distraction:** Executives and board members may be diverted from strategic planning to manage legal proceedings.
- **Increased Scrutiny:** Regulatory and investor scrutiny may intensify, requiring more detailed disclosures and internal audits.
- **Reputational Damage:** The company may suffer reputational harm, affecting customer trust, partnerships, and employee morale.
- **Internal Investigations:** Resources may be allocated to conduct internal investigations or implement compliance improvements to prevent future issues.

These factors can collectively affect the company's long-term performance and market position.","Securities class action litigation could be expensive, divert management's attention and resources, and adversely affect the company's business and financial condition. Insurance coverage may not be sufficient to cover all costs and damages.",5.0,0.747058567194379,1.0
What are the principal risks related to the economy that could negatively affect the company's portfolio companies and results of operations?,I don't know.,"The principal risks include public health crises, economic recessions, capital market disruptions, and the inability to obtain additional capital due to regulatory or market constraints.",1.0,0.23011878071577696,0.0
"What specific risks are associated with the company's subsidiary, NSBF, being an SBLC licensed by the SBA?",I don't know.,"NSBF must maintain minimum regulatory capital and comply with SBA regulations, including potential liability for SBA guaranty denials or repairs, which could transfer liability to NSBF.",1.0,0.2207224477216119,0.0
"How does the company plan to maintain its tax treatment as a RIC, and what are the potential consequences of failure?","To maintain its tax treatment as a Registered Investment Company (RIC), a company must comply with the Internal Revenue Code requirements, including:  
- Investing at least 70% of its total assets in qualifying securities (e.g., stocks, bonds, and other investments).  
- Distributing at least 90% of its net investment income to shareholders annually.  
- Maintaining sufficient diversification to avoid being treated as a ""controlled company.""  
- Meeting specific income and asset tests (e.g., derived income, asset composition).  

Failure to meet these requirements may result in:  
- Loss of RIC status, leading to corporate-level taxation on investment income.  
- Increased tax liability for the company and potentially higher taxes for shareholders.  
- Potential penalties or audits by the IRS.  

The company plans to maintain its RIC status through compliance with these rules, internal governance, and regular tax reviews.","To maintain RIC status, the company must meet source-of-income, asset diversification, and distribution requirements. Failure could subject the company to corporate-level income tax, reducing net assets and available income for distribution.",5.0,0.8224882565007748,1.0
What are the risks related to the company's investments in technology-related companies?,I don't know.,"Risks include potential obsolescence of intellectual property, equipment, and inventory due to technological advancements, which could impair the collateral value of loans made to these companies.",1.0,0.22123101698933056,0.0
How does the company's status as a BDC affect its ability to raise additional capital and the way it does so?,"As a BDC (Business Development Company), the company is eligible to raise additional capital through public offerings, private placements, and debt financing, often with favorable tax treatment and regulatory flexibility under the Investment Company Act of 1940. BDCs are required to distribute at least 90% of their net investment income to shareholders, which can influence their capital structure and ability to retain earnings. Additionally, BDCs are allowed to use leverage, which enhances their ability to invest more capital and potentially improve returns, although it also increases risk. These characteristics make BDCs attractive to investors seeking income, thereby facilitating their ability to raise capital.","As a BDC, the company is subject to restrictions on issuing common stock below net asset value and must maintain an asset coverage ratio for senior securities. These constraints affect its capital raising flexibility and methods.",4.0,0.6579025370037302,1.0
How does Newtek Business Services Corp. determine the fair value of its investments?,"Newtek Business Services Corp. determines the fair value of its investments based on the fair value hierarchy established by accounting standards, which includes observable and unobservable inputs. The company uses market-based data, such as quoted prices in active markets for identical assets (Level 1), and other observable inputs like interest rates and yield curves (Level 2) when available. For investments where observable inputs are not available, fair value is estimated using unobservable inputs (Level 3), such as internal valuation models and assumptions about future cash flows, risk, and market conditions. The specific approach depends on the nature of the investment and the availability of market data.","Newtek Business Services Corp. determines the fair value of its investments using unobservable inputs and assumptions, classifying them as Level 3 within the fair value hierarchy. This involves significant judgments about valuation methodologies and inputs such as revenue and EBITDA multiples, market yields, discounts for lack of marketability, underlying cash flows, and the impact of economic conditions.",4.0,0.9303656307793908,1.0
What critical audit matter was communicated regarding the valuation of investments?,I don't know.,"The critical audit matter communicated was the valuation of investments, which involves judgments necessary for management to select and apply valuation techniques and assumptions, the high degree of auditor judgment involved, and the extensive audit effort involved in testing the valuations.",1.0,0.29074986617163645,0.5
What is the total principal amount of PPP loans funded by NSBF during the duration of the PPP?,I don't know.,"NSBF funded approximately 10,570 PPP loans totaling $1.19 billion during the duration of the PPP.",1.0,0.21266210458578583,1.0
How does the CARES Act affect existing SBA 7(a) borrowers?,"The CARES Act provided relief to existing SBA 7(a) borrowers by allowing them to defer principal and interest payments for up to one year on all outstanding SBA 7(a) loans, including those made through the Paycheck Protection Program (PPP), without penalty or fees. This relief applied to loans with terms of at least two years, and it was designed to provide financial flexibility during the COVID-19 pandemic.","The CARES Act provided an over $2.0 trillion stimulus package, including subsidies to certain existing SBA 7(a) borrowers where the SBA paid all principal, interest, and fees on existing performing SBA 7(a) loans for six months beginning with such borrowers’ April 2020 payments.",3.0,0.8252815116229606,1.0
How does Newtek Business Services Corp. account for its equity-based compensation plan?,"Newtek Business Services Corp. accounts for its equity-based compensation plan under the fair value method in accordance with Accounting Standards Codification (ASC) 718, ""Compensation – Stock Compensation."" This involves recognizing the fair value of stock options and other equity-based awards as compensation expense over the service period, typically the vesting period. The fair value is determined using a pricing model, such as the Black-Scholes model, and the expense is recognized over the period during which employees are required to provide services to earn the award.","Newtek Business Services Corp. accounts for its equity-based compensation plan using the fair value method, as prescribed by ASC 718. For restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the date of the grant and amortizes this fair value to salaries and benefits over the requisite service period.",4.5,0.8720791445812649,1.0
How does Fusion plan to address the risk of third-party claims of intellectual property infringement?,"Fusion plans to address the risk of third-party claims of intellectual property infringement by implementing a comprehensive legal review process, conducting thorough due diligence on third-party technologies, and ensuring that all licensed or used intellectual property is properly vetted and licensed. Additionally, Fusion may include indemnification clauses in contracts with partners and vendors, and maintain insurance coverage to mitigate potential financial exposure.","Fusion plans to manage this risk by ensuring compliance with patent laws and regulations, potentially obtaining licenses when necessary, and defending against any claims through legal proceedings if needed.",4.5,0.7477578909694272,1.0
How does Fusion mitigate the risk of product liability claims?,I don't know.,"Fusion mitigates this risk by maintaining product liability insurance, ensuring strict quality control in manufacturing, and adhering to regulatory standards in the development and marketing of its products.",1.0,0.20391244960147098,0.0
What is the primary focus of the company's business?,I don't know.,"The company is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, particularly through its Targeted Alpha Therapies (TAT) platform.",1.0,0.19017139395307137,0.5
"What strategic collaboration has the company entered into, and what are the key terms of this collaboration?",I don't know.,"The company has entered into a strategic collaboration agreement with AstraZeneca to jointly discover, develop, and commercialize next-generation alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. The collaboration leverages Fusion’s TATs platform and expertise in radiopharmaceuticals with AstraZeneca’s leading portfolio of antibodies and cancer therapeutics, including DDRis. Both companies will retain full rights to their respective assets.",1.0,0.20354981150174992,0.0
How does the company plan to address the potential for reduced profitability due to government and third-party payor reimbursement policies?,I don't know.,"The company must engage in a time-consuming and costly process to provide scientific and clinical support for the use of its products to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained. The company may also need to negotiate lower prices for its products to be covered by government health programs and commercial insurance, which could impact profitability.",1.0,0.26331960425998074,0.5
What is the company's approach to intellectual property protection for its products and technologies?,I don't know.,"The company seeks to protect its products and technologies by filing U.S. and foreign patent applications related to its proprietary technology, inventions, and improvements. It also relies on trade secrets, know-how, continuing technological innovation, and in-licensing of third-party intellectual property to develop and maintain its proprietary position.",1.0,0.249306887907143,0.0
What significant changes did Jefferies Financial Group Inc. make to its operating segments in the first quarter of 2020?,I don't know.,"In the first quarter of 2020, Jefferies Financial Group Inc. appointed co-Presidents of Asset Management and created a separate operating segment for asset management activities previously included in the Investment Banking, Capital Markets, and Asset Management segment, as well as those previously included in the Merchant Banking segment.",1.0,0.22451829743220245,0.5
How does Jefferies Financial Group Inc. manage its exposure to credit risk associated with derivative activities and securities financing transactions?,"Jefferies Financial Group Inc. manages its exposure to credit risk associated with derivative activities and securities financing transactions through a combination of credit risk oversight, collateral management, and counterparty risk assessment. The company employs a comprehensive credit risk management framework that includes setting credit limits for counterparties, regularly monitoring counterparty exposures, and requiring collateral (such as cash or securities) to be posted to mitigate risk. Additionally, Jefferies utilizes valuation models and stress testing to assess potential credit exposures, and it adheres to regulatory requirements and internal policies designed to ensure appropriate risk mitigation.","Jefferies Financial Group Inc. manages its exposure to credit risk through master netting agreements, master securities lending agreements, master repurchase agreements, or similar agreements and collateral arrangements with counterparties. These agreements provide protection in bankruptcy in certain circumstances and enable receivables and payables with the same counterparty to be settled or otherwise eliminated by applying amounts due against all or a portion of an amount due from the counterparty or a third-party.",4.0,0.7138285902189254,1.0
What is the significance of the foreign currency translation adjustments in Jefferies Financial Group Inc.'s financial statements?,"Foreign currency translation adjustments in Jefferies Financial Group Inc.'s financial statements reflect the impact of changes in foreign exchange rates on the company's foreign operations when translating their financial results into the reporting currency (usually U.S. dollars). These adjustments are recorded in other comprehensive income (OCI) and affect the equity section of the balance sheet, specifically within accumulated other comprehensive income (AOCI). 

The significance lies in providing transparency about the financial impact of currency fluctuations on the company's global operations, helping investors understand how exchange rate movements influence the value of foreign assets, liabilities, and earnings. These adjustments are non-cash and do not affect net income but can affect the company’s overall financial position and equity.",Foreign currency translation adjustments result from translating the financial statements of foreign subsidiaries from their functional currency into the reporting currency (U.S. dollars). These adjustments are included in accumulated other comprehensive income (loss) and can significantly impact the company's equity and financial position.,5.0,0.7427608006427124,1.0
How does SuRo Capital Corp value its investments at fair value?,"SuRo Capital Corp values its investments at fair value using methods consistent with the fair value measurement framework under generally accepted accounting principles (GAAP). This typically involves using observable market data, such as quoted prices in active markets, or employing valuation techniques like discounted cash flow models, comparables analysis, or option pricing models when market data is not readily available. The specific methods and assumptions are disclosed in the company's financial statements and notes to the consolidated financial statements. For detailed information, refer to SuRo Capital Corp's most recent filings with the SEC.","SuRo Capital Corp values its investments at fair value using a hierarchy that prioritizes the inputs to valuation techniques. Level 1 assets are valued based on unadjusted quoted prices in active markets for identical assets. Level 2 assets use observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities. Level 3 assets use unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability.",4.0,0.7901764843442503,1.0
What measures has SuRo Capital Corp taken to ensure compliance with the RIC tax provisions of the Code?,I don't know.,SuRo Capital Corp has elected to be treated as a RIC under Subchapter M of the Code and intends to qualify for tax treatment as a RIC. The Company is required to meet certain income and asset diversification tests and distribute dividends of an amount generally at least equal to 90% of its investment company taxable income to its stockholders. The Company has taxable subsidiaries that hold certain portfolio investments to limit potential legal liability and comply with source-income type requirements.,1.0,0.2500827873617704,0.5
What are the key features of Waste Management's Employee Stock Purchase Plan (ESPP)?,I don't know.,"The key features of Waste Management's ESPP include employees being able to purchase shares of common stock at a discount, with purchases made at the end of offering periods with funds accumulated through payroll deductions. The discount is 85% of the lesser of the market value of the stock on the first and last day of the offering period.",1.0,0.2910127351723552,0.0
How does Waste Management assess and manage its long-lived assets for potential impairment?,"Waste Management assesses and manages its long-lived assets for potential impairment by regularly evaluating these assets for indicators of impairment, such as significant changes in the business environment, technological obsolescence, or underperformance relative to expectations. When such indicators are present, the company performs an impairment test by comparing the carrying value of the asset to its estimated future undiscounted cash flows. If the carrying value exceeds the undiscounted cash flows, an impairment loss is recognized, measured as the difference between the carrying value and the fair value of the asset. The company follows applicable accounting standards, including ASC 360-10, to ensure consistent and transparent impairment evaluation and reporting.","Waste Management assesses its long-lived assets for potential impairment by monitoring the carrying value for potential impairment indicators. If an impairment indicator occurs, the company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. If the carrying value exceeds the undiscounted cash flows, the company measures the impairment by comparing the fair value of the asset or asset group to its carrying value.",5.0,0.8798642629570541,1.0
"What are the primary sources of revenue for Waste Management, and how do they contribute to the overall revenue mix?","The primary sources of revenue for Waste Management, Inc. include residential, commercial, and industrial waste collection services, landfill operations, recycling and resource recovery, and environmental services. 

Residential waste collection is a major contributor, providing steady, recurring revenue from household waste pickup. Commercial and industrial waste services generate significant revenue from businesses and large-scale operations that produce higher volumes of waste. Landfill operations contribute through tipping fees charged for waste disposal. Recycling and resource recovery services add value by processing recyclable materials and selling them to manufacturers. Environmental services, such as hazardous waste disposal and remediation, also contribute, albeit in smaller portions, through specialized, fee-based services.

Together, these segments form a diversified revenue mix, with residential and commercial waste collection typically forming the largest share, followed by landfill operations and recycling, helping ensure stable and resilient overall revenue.","The primary sources of revenue for Waste Management are collection, landfill, transfer, and recycling services. These services contribute to the overall revenue mix, with collection and landfill services typically being the most significant contributors.",4.5,0.8569066122478792,1.0
"How does Waste Management handle its environmental remediation liabilities, and what was the total amount of such liabilities as of December 31, 2020?",I don't know.,"Waste Management handles its environmental remediation liabilities by recognizing and accruing for an estimated remediation liability when it determines that such liability is both probable and reasonably estimable. The total amount of environmental remediation liabilities as of December 31, 2020, was $230 million.",1.0,0.19914170927430597,0.0
"What are the key financial covenants associated with Waste Management's debt agreements, and how does the company ensure compliance?",I don't know.,"The key financial covenant associated with Waste Management's debt agreements is the maximum total debt to consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) ratio (the ""Leverage Ratio""). The company ensures compliance by monitoring its financial position and maintaining significant headroom within the Leverage Ratio.",1.0,0.15013257647595574,0.0
How does ridinilazole aim to differentiate itself from existing treatments for CDI?,"Ridinilazole aims to differentiate itself from existing treatments for Clostridioides difficile infection (CDI) by selectively targeting the pathogens responsible for the infection while preserving the beneficial gut microbiota. Unlike broad-spectrum antibiotics, which can disrupt the normal gut flora and contribute to recurrent infections, ridinilazole is designed to have a narrow spectrum of activity, reducing the risk of resistance and recurrence. This targeted approach may lead to improved efficacy and lower rates of CDI recurrence compared to current therapies.","Ridinilazole is designed to selectively target the bacterium Clostridioides difficile while preserving the gut microbiome, potentially reducing recurrence rates and improving sustained clinical response rates compared to broad-spectrum antibiotics like vancomycin.",5.0,0.8536863709359761,1.0
What financial support has Summit Therapeutics received for the development of ridinilazole?,Summit Therapeutics has received financial support for the development of ridinilazole through a collaboration with the U.S. Department of Defense (DoD). The company was awarded a grant from the DoD's Congressionally Directed Medical Research Programs (CDMRP) to support the development of ridinilazole for the treatment of *Clostridioides difficile* infection (CDI). This grant was part of the DoD's efforts to fund research into antimicrobial resistance and infectious diseases.,Summit Therapeutics has received a contract from the Biomedical Advanced Research and Development Authority (BARDA) worth up to $72.5 million to support the ongoing Phase 3 clinical trials and potential regulatory applications for ridinilazole in the United States.,3.0,0.7875646016330835,1.0
What are the key competitive factors affecting the success of Summit Therapeutics' product candidates?,I don't know.,"The key competitive factors include efficacy, safety, convenience, price, and the availability of coverage and reimbursement from government and other third-party payors.",1.0,0.18610799570560024,0.0
"What are the potential risks associated with the company's reliance on government funding for its lead product candidate, ridinilazole?",I don't know.,"Risks include the possibility of the government terminating the funding contract, changes in government budgets and research priorities, delays in development activities, and increased costs of commercialization and production due to imposed requirements. These factors could force the company to seek alternative funding sources, which may not be available on favorable terms.",1.0,0.23177994930702314,0.0
What are the key factors that contributed to the increase in net interest income during 2020?,I don't know.,"The increase in net interest income during 2020 was primarily due to lower interest expense from interest-bearing liabilities driven by lower rates paid and a shift in mix to lower cost deposits, as well as the favorable impact of higher average interest earning asset balances.",1.0,0.20779277479645505,0.0
How did the COVID-19 pandemic impact the provision for credit losses in 2020?,"The COVID-19 pandemic significantly impacted the provision for credit losses in 2020, leading to a substantial increase across financial institutions. The uncertainty and economic disruption caused by lockdowns, business closures, and rising unemployment resulted in higher credit risk, prompting banks and lenders to increase their credit loss provisions under the CECL (Current Expected Credit Loss) accounting standard. This required institutions to estimate expected losses over the life of their loans, factoring in the pandemic's economic effects. As a result, many financial entities recorded higher provisions for credit losses, reflecting the anticipated rise in defaults and delinquencies.","The COVID-19 pandemic significantly impacted the provision for credit losses in 2020 by causing a deterioration of economic conditions, which resulted in a worsening of the economic forecasts used for calculating expected credit losses and downgrades reflecting weakness in the financial condition of certain clients.",5.0,0.7009997674087692,1.0
What measures were taken by HSBC USA to manage liquidity and funding risk during the COVID-19 pandemic?,"During the COVID-19 pandemic, HSBC USA implemented a range of measures to manage liquidity and funding risk, consistent with global HSBC Group practices. These included:

1. **Strengthening Liquidity Buffers**: HSBC USA maintained robust liquidity coverage ratios (LCR) and net stable funding ratios (NSFR) to ensure it could withstand short-term shocks and meet its obligations under stress scenarios.

2. **Enhanced Risk Monitoring and Stress Testing**: The bank intensified its monitoring of liquidity and funding risks through advanced stress testing and scenario analysis to assess vulnerabilities under various pandemic-related economic conditions.

3. **Optimized Funding Mix**: HSBC USA diversified its funding sources, relying more on stable retail deposits and core wholesale funding while minimizing reliance on volatile wholesale markets.

4. **Liquidity Management Framework**: The bank utilized its centralized liquidity management framework, leveraging its global funding platform to ensure access to liquidity across different currencies and markets.

5. **Government Support Utilization**: HSBC USA participated in U.S. government support programs such as the Federal Reserve's lending facilities (e.g., the Primary Dealer Credit Facility) to bolster liquidity when needed.

6. **Contingency Planning**: The bank enhanced its contingency funding plans (CFP) to ensure rapid response capabilities and maintained high levels of high-quality liquid assets (HQLA).

These measures ensured the bank’s resilience during the economic disruption caused by the pandemic.","During the COVID-19 pandemic, HSBC USA actively raised deposits, increased short-term borrowings in the form of securities sold under repurchase agreements, and borrowed from the Federal Home Loan Bank to support elevated client demand for loans while maintaining adequate liquidity.",4.5,0.7382388996661644,1.0
What was the impact of the LIBOR transition on HSBC USA's operations?,"The LIBOR transition impacted HSBC USA by necessitating significant operational changes, including updating contracts, modifying risk management systems, and ensuring compliance with regulatory requirements. HSBC USA worked to transition financial products and services from LIBOR to alternative reference rates, such as SOFR, to maintain market continuity and mitigate financial and legal risks. The transition required coordination across legal, risk, and IT departments to ensure smooth implementation and customer communication.","The LIBOR transition process involved developing alternative rate product capabilities and transitioning legacy contracts. This transition could have a range of adverse impacts on HSBC USA's business, including legal proceedings or other actions regarding the interpretation and enforceability of provisions in LIBOR contracts and regulatory investigations or reviews.",4.0,0.7946562463341094,1.0
How did HSBC USA manage its credit risk during the economic uncertainty caused by the COVID-19 pandemic?,"HSBC USA managed its credit risk during the economic uncertainty caused by the COVID-19 pandemic by implementing a range of measures, including enhancing credit risk monitoring, increasing loan loss provisions, and maintaining strong capital and liquidity buffers. The bank also provided loan deferrals and payment relief programs to borrowers in distress, while closely assessing the creditworthiness of affected sectors. These actions helped mitigate potential losses and maintain financial stability during the crisis.","HSBC USA managed its credit risk during the pandemic by re-reviewing the credit ratings assigned to substantially all of its material commercial loans, closely monitoring the performance of these loans, and taking necessary credit actions where warranted.",4.5,0.8320084622338899,1.0
"What was the strategic plan announced by HSBC USA in February 2020, and what were its expected financial impacts?","In February 2020, HSBC USA announced a strategic plan to significantly reduce its branch network and focus on digital banking and wealth management. The plan involved closing up to 200 branches by 2023 and reducing its workforce by approximately 1,500 employees. The goal was to streamline operations, improve efficiency, and enhance its competitive position in the U.S. market by shifting resources toward digital and high-growth areas.

The expected financial impact included cost savings of up to $500 million annually by 2023, driven by lower operational expenses from branch closures and workforce reductions. The plan also aimed to improve return on equity and overall profitability in the long term.","The strategic plan announced in February 2020 aimed to restructure operations in alignment with HSBC’s global strategy, focusing on refocusing wholesale operations and restructuring retail operations. The expected financial impact included pre-tax charges of approximately $520-$590 million over the two-year period of 2020-2021.",4.0,0.7692858763583728,1.0
